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The Ph.D project titled “New Encapsulation technologies for the development 
of in situ gelling micro-nano particulate systems for the wound healing” aimed 
to develop novel topical formulations by innovative technologies, based on 
supercritical CO2 (SC-CO2) and nanospray drying. The specific goal of the 
project was the design and development of in situ gelling formulation in form 
of powders or aerogels for wound healing using biodegradable and 
biocompatible polymers, active in wound healing process, as carrier for the 
encapsulated drugs. Uniform filling of the wound bed, good transpiration 
properties and controlled drug release profiles have been used to evaluate the 
quality of the different devices.  
During the first year, prilling/supercritical antisolvent extraction (SAE) 
tandem technique and supercritical assisted atomization (SAA) were studied.  
Prilling/SAE was tuned for the first time for the production of aerogel beads. 
Alginate based aerogels with narrow size distribution and high fluid uptake 
values were successfully obtained after an accurate study of the process 
parameters and solvent exchange conditions needed to use SAE as curing 
process. 
SAA was applied for the production of an in situ gelling dry powder 
formulation, loaded with gentamicin. High mannuronic content alginate and 
low methoxyl degree pectin were used as carrier. Very high process yields 
were obtained (up to 71%), and the powder obtained by SAA showed good 
technological properties and were able to overcome gentamicin 
hygroscopicity. When in contact with simulated wound fluids powders moved 
rapidly to gel enabling a prolonged release of the drug (between 6 and 10 
days). Furthermore, formulations were able to increase antimicrobial activity 
of GS on both S. aureus and P. aeruginosa strain. 
The second year was focused on nano-spray drying technique. It was applied 
for the production of an in situ gelling nanoparticulate powder using an 
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alginate and pectin blend as excipient for gentamicin formulations. Operative 
parameters were set to produce particles in nanometric size (~350 nm) with 
very high process yield (92%) and good encapsulation efficiency (83%). 
Powder formulations were able to gel rapidly when in contact with simulated 
wound fluids, had good transpiration and adhesive properties and were able to 
prolong drug release in vitro (till 6 days). Antimicrobial activity of GS loaded 
formualtions on both S. aureus and P. aeruginosa strain were also prolonged. 
In the same year, a hydrogel based on alginate high mannuronic content or 
chitosan low molecular weight loaded with Ac2-26 Annexin 1 derived peptide 
was developed to test the ability of the peptide healing promoting activity. 
Stability of Ac2-26 was increased due to the formation of ionic interactions 
between peptide and polymers. Ac2-26 hydrogel formulations were tested on 
wounded mice. In vivo experiments pointed out the efficacy of the alginate 
loaded hydrogel to increase wound closure, about 60% faster compared to 
control. 
During third year, in order to enhance technological properties of the in situ 
nanoparticulate powder produced during the second year, a three components 
polymer blend (alginate, chitosan and amidated pectin) was used to test nano 
spray drying technology. Doxycycline was used as antimicrobial drug due to 
its well-known inhibiting activity against MMP9 that could enhance wound 
healing process. Formulations produced by nano spray drying presented very 
high process yields (up to 99%) and encapsulation efficiency (up to 98%) 
while powder gelation time was also reduced (5 minutes) enabling fast and 
complete covering of a wound. A prolonged drug release profile was observed 
due to drug/polymer interaction, as well as antimicrobial activity against S. 
aureus strain was enhanced (till 7 days) compared to pure doxycycline.  
Doxycycline was also used as model drug to test the feasibility of prilling/SAE 
tandem technique for the production of core/shell aerogel particles. Aerogels 
were obtained by prilling in co-axial configuration, using amidated pectin as 
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core and alginate high mannuronic content as shell. Particles were able to 
easily gel when in contact with exhudates due to the wide aerogel exposed 
surface area, absorbing large amount of fluid. Core and shell were well 
separated with doxycycline distributed homogeneously only into the pectin 
core. As a result, aerogels presented high encapsulation efficiency (up to 87%) 
and prolonged drug release, till 48 hours.  
Moreover, durting the Ph.D course, three months were spent at University of 
Santiago de Compostela, to study the feasibility of supercritical impregnation 
method coupled with prilling and supercritical drying to manufacture novel 
wound healing aerogel devices. Ketoprofen and norfloxacin, were used as 
model drugs due to their solubility in SC-CO2. As expected, aerogels 
presented high porosity, very useful to absorb large quantities of exhudates. 
Impregnation process was successful for ketoprofen whereas norfloxacin 





























































































1.1 Skin wounds and reparation process 
The integumentary system is the widest apparatus in the human body, and 
consists of skin, and appendages that are hair, nails and exocrine glands. It 
represents 16% of the total body weight, with a surface of 1.5-2 m2. It has 
many functions as the protection of the body from the external environment, 
the thermoregulation, the excretion of small quantities of waste products, the 
deposition of nutrients and the syntesis of vitamin D. Furthermore, it is the 
most important sense organ, containing different receptors for pain, 
temperature, and tact. Adult skin consists of different layers: epidermis, derma 
and hypoderm.  
Epidermis consists of corneal, germination stratus and melanocytes. Derma is 
constituted by connective tissue, with the sensorial receptors. Hypoderm is a 
collagen-rich dermal connective tissue providing support and nourishment. 
Hairs and glands also called appendages are linked to epidermis but project 
deep into the dermal layer. 
Because of skin acts as a protective barrier against the outside world, any 
damage should be mended rapidly and efficiently, leading to the restoration of 
the function (1). 
The term “wounds” includes all types of skin injuries: open (lacerations, 
abrasions, burns) and closed (hematomas), superficial (abrasions, lacerations, 
burns) and deep (diabetic foot, pressure sores), acute and chronic. 
A chronic wound is one that fails to heals whithin a reasonable time (usually 
three months), an acute wound heals more quickly, causing minimal functional 
loss in the part of the body damaged (2). 
To develop an appropriate therapeutic program, able to take into account the 
general patient’s status, healt and compliance, it is necessary to perform an 
accurate anamnesis and to evaluate the kind of injury, in order to prevent 
complications and to preserve functions.  
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Wound healing is a complex physiological multistage process composed of a 
sequence of precise events that lead to complete skin reparation. Generally, 
they are divided in four parts: 
1) When the lesion occurs, a local haemorrhage happens a clot is formed 
to plug the defect, inhibiting further microbial access. The clot consists 
of platelets embedded in a mesh of crosslinked fibrin fibers derived by 
thrombin cleavage of fibrinogen, together with smaller amounts of 
plasma fibronectin, vitronectin, and thrombospondin. Mastocytes begin 
the inflammatory response. 
2) After a few hours, cells from germinal layer migrate along the edges of 
the wound, to replace the empty space. Neutrophils and monocytes are 
recruited from the circulating blood in response to molecular changes 
in the surface of endothelial cells lining capillaries at the wound site. 
The role of neutrophils is not only to clear the initial rush of 
contaminating bacteria, but also they are a source of pro-inflammatory 
cytokines that can activate local fibroblast and keratinocytes (3). 
3)  After a week, the fibrin clot dissolves by the fibrinolytic enzyme 
plasmin derived from plasminogen and the number of capillary 
decreases.  Various members of the matrix metalloproteinase (MMP) 
family, each of which cleaves a specific subset of matrix proteins, are 
also up-regulated by wound-edge keratinocytes. MMP-9 (gelatinase B) 
can cut basal lamina collagen (type IV) and anchoring fibril collagen 
(type VII), and is thought to be responsible for releasing keratinocytes 
from their tethers to the basal lamina (4). Furthermore, the phagocytic 
activity is almost over, and fibroblasts produce collagen fibre and 
amorphous fundamental substance. 
4) After a few weeks, the rind is detached and the denuded wound surface 
has been covered by a monolayer of keratinocytes, and a new stratified 
epidermis with underlying basal lamina is reestablished from the 
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margins of the wound inward (5). Coincident with the onset of basal 
lamina synthesis, MMP expression is shut off, and new 
hemidesmosomal adhesions to the basal lamina reassemble. The last 
components of the epidermal attachment machinery to reach maturity 
are the anchoring fibrils that link basal lamina to underlying connective 
tissue (6). A light depression is often observed in the site of the lesion, 
but the fibroblast activity continues, producing fibrous scar tissue.   
  
The type of wound and the healing environment influence the relative 
contribution of each step.  
Many pathological conditions and the possibility of bacterial infection, as well 
as the exacerbation of inflammatory phase, do not permit to reach the healing 
condition and the wound remains in a chronic state with many aftermaths on 
the health. 
 
Figure 1: A schematic representation of the healing process phasis.  
1.1.1 Factors influencing healing process 
A patient with chronic skin wounds, in general, is elderly, with pain and poor 
quality of life. The patology that caused the lesion is often complex and 
multifactorial. It is necessary a diagnostic accurate classification and a 
therapeutic program focused on etiology and on the lesion status, also 
considering comorbilities and perilesional skin conditions. 
Many systemic factors can influence the healing process such as: 
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1) dismetabolisms as diabetes mellitus 
2) circulatory deficiency due to arteriosclerosis and venous stasis 
3) ormonal disease, for example glucocorticoids can ihnibit inflammation 
and collagen synthesis. 
Diabetes mellitus is the most important reasons for the onset of chronic 
wounds.  
Although chronic hyperglycemia is an important reason determining diabetes 
complications, molecular mechanisms are not completely clear yet. 
A hypothesis suggests that the increase of intracellular glucose concentration 
determines the formation of advanced glycosylation end products (AGE).  
AGE products form crosslinks between proteins, accelerate arteriosclerosis, 
alter extracellular matrix structure and composition. 
Another hypothesys postulates that hyperglycemia increases the formation of 
diacylglycerol, inducing activation of protein kinase (PKC). 
PKC is able to alter fibronectin genes transcription, collagen type IV, 
contractile proteins and extracellular matrix proteins in both endothelial cells 
and neurons. Many diabetes complications are related to these mechanisms 
(7).  
There are other systemic factors that are directly correlated to general health 
status of the patients, they are different and depend on the etiology of the 
wound (8). 
1) Age of the patient (the healing disorders can depend on a weak 
immune state, increased chronic, degenerative and disabling 
pathologies). 
The biomedical and socioeconomic burdens posed by wound complications 
are worsened by the aging global population. As the global population ages, so 
does the nursing home population, and this will lead to more pressure ulcers. 
In Europe, similar to that in the US, aging of the population is associated with 
increase in the number of patients with a chronic wound (9). 
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2) Nutritional state- obesity. 
According to the Center for Disease Control (CDC) and World Health 
Organization (WHO), in adults a body mass index (BMI) of 25 or more is 
considered “overweight” and a BMI of 30 or more is considered “obese”. In 
2007, more than 1.1 billion adults worldwide were overweight and 312 million 
of them were obese (10). As the number of larger patients increases, so do the 
health problems related to obesity, including wound healing. 
3) Post surgical complications: thrombosis, thromboembolism. 
4) Trauma or shock aftermaths also after operations with extracorporeal 
circulations. 
5) Drugs as corticosteroids.  
Different studies, on the use of corticosteroids in the perioperative period, 
converge on an approximately 30% reduction in wound tensile strength at 
cortisone doses of 15 to 40 mg/kg/day, equivalent to approximately 200 to 560 
mg/day of prednisone in a 70-kg person. Nevertheless, wound healing may be 
affected by the duration of systemic corticosteroid exposure (11). 
Furthermore, local factors can delay directly the tissue reparation process 
acting with different mechanisms. 
For example, perilesional skin maceration due to copious fluid emission, and 
recurring traumas, happening expecially if the wound is localized in particular 
position exposed to chafing or presence of necrotic tissue can worsen lesion 
condition. Inadequate blood supply, as in presence of circulatory deficiencies 
and pressure on the wound, as in case of bedridden patiens, are other factors, 
but the most important are the local infections. 
Also local factors can influence the healing process such as infections (12). 
The impact of microorganisms on chronic wounds has been extensively 
studied and reviewed using different approaches to elicit their possible role in 
non-healing (13). Staphylococcus aureus and coagulase-negative 
staphylococci have been the predominant organisms isolated from both 
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prospective, purpose-collected samples and retrospective analysis of clinical 
investigations. S. aureus has been reported in frequencies varying from 43% of 
infected leg ulcers (14) to 88% of non-infected leg ulcers (15) whereas 
Staphylococcus epidermidis has been reported in 14% of venous ulcer 
specimens (16) and 20.6% of diabetic foot ulcers. Pseudomonas aeruginosa is 
another frequently identified organism and has been found in 7–33% of ulcers 
(15, 17, 18). A number of other aerobic species have also been reported, 
including Escherichia coli, (19, 20) Enterobacter cloacae (15, 16), Klebsiella 
species (20), Streptococcus species (19, 21, 22), Enterococcus species (15, 23) 
and Proteus species (24). In addition to aerobes, anaerobic organisms are 
frequently identified in wounds. The most common isolates found in both the 
infected and non-infected leg ulcers were Peptostreptococcus species and 
pigmented and non-pigmented Prevotella/Porphyromonas species (14). 
Many of the problems previously decribed, can determine huge disturbances in 
the tissue reparation (25) that appears as seroma that are collections of serous 
exudate that can form infected abscesses, or necrosis of soft parts, also 
hematomas, expecially in closed wounds or cheloids. In this case granulation 
tissue can occur, extending beyond the wound borders, without regression. 
1.2 Chronic skin wounds 
Chronic skin wounds and bedsores represent a relevant problem of health care 
that involves human, technological, material and economic resources.  
 Often disguised as a comorbid condition, chronic wounds represent a silent 
epidemic that affects a large fraction of the world population and poses major 
and gathering threat to the public health and economy of many countries.  
In developed ones, it has been estimated that 1 to 2% of the population will 
experience a chronic wound during their lifetime (26). In the United States 
alone, chronic wounds affect 6.5 million patients (27, 28). In the Scandinavian 
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countries, the associated costs account for 2–4% of the total health care 
expenses (29). 
Bedsores are more frequent in patients with compromised tissue perfusion due 
to neuromata impairment due to pathologies such diabetes mellitus and in 
lying in bed patients. Because of these two conditions are often found in old 
people, the problem increases with the aging of population: the incidence of 
bedsores in hospitalized people increases from 4-9% to 10-25% in older 
patients. Life quality is compromised, for the debilitating and painful wounds 
that not permit to do working activities and to live life normally (30).  
Old people with pressure sores spend about 250 euro per month for medical 
devices, an outgo completely paid by patients. According to the study, 2 
million of Italians with ulcers, pressure sores or diabetic foot affect public 
healt costs for about 1 billion euro per year.  
The investigation, carried out on the whole national territory on people with 
cutaneous ulcers highlited that on 1004 respondents, a representative sample 
of 2 million of Italian with complicated wounds, suffer mainly of: 
 Leg ulcers – 53.3% 
 Pressure sores- 24.2% 
 Diabetic foot- 23.3% 
Between the most relevant problems, pain stands out and in the 42.7% of 
respondents it is chronic, whereas treatment costs are estimated between 100 
and 250 euro per month for 36% of people and exceed 250 euro for 13.2% (31, 
32). 
Actually, the problem is relevant also because of the long assistance required: 
for example, ulcers care can involve the 60% of working time of nurses, with 
high care costs.   
The most important chronic wounds are described below. 
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Pressure sores: they are areas of tissue damage, due to pressure, clutch or 
sprain. In this group are included ulcers and bedsores that are an important 
problem for hospitalized patients.  
The optimal treatment can be divided into three phases: 
1) Remove the pressure, changing the patient position in the bed and using 
helpful aids. 
2) Topic treatment of the wound  
3) Treatment of comorbilities that can interfere with the normal healing 
process as malnutrition or infections. 
 
Figure 2: A schematic representation of pressure sores development. 
Vascular lesions of lower limbs: they have a venous, arterial or mixed 
etiology. The localization is often below the knee to the feet and their duration 
ranges from eight to ten weeks. Chronic ulcers are more frequent in older 
patients, determining high social costs. Vascular lesions have a frequence of 
1.8 to 3.05 per thousand, and the 10 per thousands of adult population had at 
least once a lower limb wound (33). Optimal treatment is firstly the 
elastocompressive bandaging with topical drug administration. 
Diabetic foot sores: they begin when diabetic neuropathy and arteriopathy of 
lower limbs compromise foot function and structure. The pathological outline 
can be the neuropathic foot or the ischemic one, but in old age they often exist 
contemporarly giving the so called neuroischemic foot (34). 
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 An important complication is microbial infection; this is the most important 
reason of amputation, infact 50% of amputations regard diabetics. 
World Healt organisation estimates that in 2025 more than 300 million people 
will become diabetic, compared to the 120 million of 1996. About 15% of 
diabetics will have a foot ulcer that will require medical care (33). 
The ideal treatment of diabetic foot sores is: 
1) Local treatment of wounds 
2) Treatment of infections, if present. 




Figure 3: A type of diabetic foot wound 
1.2.1 Systemic treatments 
Different systemic active molecules are frequently administered to enhance the 
natural healing process, also as first line treatment, and they are specific for 
the type of injury identified. 
Venous ulcers require, besides compression therapy, oral pentoxyfilline which 
is effective, but more adverse events (mainly gastrointestinal disturbances) are 
frequently found in the treated group (35). There is no current evidence on the 
effectiveness on the routine use of systematic antibiotics. Regard the use of 
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oral flavonoids there are some experimental data affected by bias, so that 
results are not completely reliable (36). 
Regarding pressure sores, available evidence from four Cochrane systematic 
reviews showed no effectiveness of enteral or parenteral nutrition (i.e., zinc or 
protein suppletion) or nutritional supplements (i.e., vitamin C) as treatment 
modalities for pressure ulcers (37, 38). 
Hyperbaric oxygen therapy, granulocyte-colony stimulating factor (G-CSF) 
administration are advised for diabetic foot sores treatment (39). Adding 
hyperbaric therapy to usual care appeared to increase the healing of diabetic 
ulcers after 6 weks, whereas evidence is lacking that G-CSF daily injection 
might cure diabetic foot infections or improve ulcer healing. Therefore, G-
CSF is not recommended in the treatment of relatively mild infections (40). 
The use of systemic antibiotic requires many daily doses, due to the short half-
life of many antimicrobial agents (such as gentamicin). Many side effects and 
the development of resistant bacteria are possible, whereas a topical treatment 
can overcome most of these problems. 
1.2.2 Topical treatments 
The practice of wound care has improved tremendously and evolved over the 
years. 
The Greek physician Galen (120-201A.D) had noted empirically that wounds 
heal optimally in a moist environment. However, for almost 2000 years, 
therapeutic efforts had focussed on drying the wound site with absorptive 
gauzes serving as mainstay for wound management (41). 
Topical treatments present a series of advantages as high drug concentration at 




The importance of a topical application is particularly apparent in ischemic 
wounds, in which dependable dispatch of a systemic (ie, bloodstream) 
antimicrobial to the damaged tissue cannot be assured (42). 
Wound care includes a series of action to be done to improve general patient’s 
conditions. 
After an accurate wash with saline solution to remove debris, the use of 
antiseptics as clorexidrin or povidone iodine (43) to clean deeply the wound 
bed and to reduce bacterial contamination by inhibiting the growth of 
microorganisms is advised if the wound is infected.  
Clorexidrin and povidone are better than fuxine, gentian violet, mercury 
chromium that have a reduced antiseptic activity and do not allow to evaluate 
the healing progression (44, 45) .  
However, antiseptics may increase the intensity and duration of inflammation 
(46), and they have also been shown to be toxic to human keratinocites and 
fibroblasts (47) and to retard epithelialization. The deep of wound is very 
important to know, in order to evaluate the risk/benefit ratio of the antiseptic 
use. 
Topical treatment of infected wounds is very important because the presence 
of necrotic tissue and the poor blood supply do not allow to reach adequate 
concentration of antibiotic systemically administred and the growth of 
bacterial resistent lines is very frequent. In this case, a local wound control is 
needed by the use of proper device, containing active pharmaceutical 
ingredients such as antibiotic, silver or growth factor after abundant cleansing.  
Following the guide lines advices, wound dressings should remain as long as 
possible on the wound, because frequent changes can induce a local 
temperaure decrease, with consequent slowdown of cell replication and then 
delay in healing process (48). Furthermore, classic devices on market often 
determine a perilesional skin removal stress, adding other damages. 
Changing medication is nedeed: 
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1) When the absorbent capacity of the device is saturated, and wound 
fluids are not manageable any more. 
2) When it appears fragmented, and then the protection aganist external 
contamination does’t work any more. If this phenomenon is frequent, 
it’s important to evaluate the choice of device, considering a 
replacement. 
The idel device, not existing yet on the market, should properly absorb the 
excess of exudate, control the bacterial growth, fill the wound bed 
allowing at the same time the correct traspiration and the control of drug 
release and of bacterial growth, avoid removal trauma. 
Advanced device use is not advised in case of: bleeding, allergy to one of 
the formulation components, skin cancer, wet gangrene, fistula. 
1.3 Types of treatments on the market 
Topical devices are very useful to stimulate the healing process and, at the 
same time, to prevent contamination: sometimes, local treatment should be 
preceded by other precaution (as changing the patient’s position in case of 
pressure sores) to enhance the medication result. 
It is possible to distinguish between the self-consistent formulation when it is 
possible to put it directly on the wound, while other types require a support or 
device for administration. 
The “ideal” medication should have many characteristics useful to obtain rapid 
effects as well as to assure patients’ compliance. They should absorb the 
excess of exudates, provide a moist microenvironment in order to guarantee 
the correct transpiration, they should be sterile/clean, easy to use and 




A great number of devices for local drug administration containing active 
pharmaceutical ingredients are on the market, but the ideal one is not exising 
yet. 
 The choice of the appropriate device should take into account many factors as 
the kind of injury, the site, the dimension, the presence of infections, the 
typology and quantity of exudate, and the care goals. 




Simple gauzes are used only to hide lesions and for the protection from 
external insults.  The antiseptic contains active substances that can decrease 
the bacterial charge on the lesion. The fatty medications contain fatty 
substances able to reduce adherence, and to maintain hemostasis. The main 
disadvantages of traditional devices regard the accidental removal of 
granulation tissue, the patient’s difficulties to maintain a correct personal 
hygiene, the risk of infections, the loss of liquids and the lesion dehydration.  
Advanced medication can help the reparative processes, also maintaining a 
moist microenvironment. The categories of products now on the market 
include: alginates, polyurethanes foams, hydrogels, hydrocolloids, hydrofibres.  
They are impermeable to virus, bacteria, determining a thermal stability useful 
for healing. However, they cannot be used in infected wound because they can 
worsen the conditions (49).  
Only formulations nowadays on the market containing micronized silver can 
help infections. Silver mechanism of action is related to Ag+ ions, which 
inhibit cellular functions, such as energy production, enzymatic function and 
cellular replication.  
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Silver in Ag-antibiotic mixtures are frequently used to inhibit bacterial growth 
(silver sulphadiazine ointment or cream- “Sofargen”). The problem of this 
product is related to the poor durability. Infact, many applications per day are 
required. Other kind of products are “Hyalosilver” composed by ialuronic acid 
and silver, “Katoxyn” composed by benzoylperoxide and silver. 
A different formulation is “Contreet M” that is a polyurethane foam with this 
active, indicated in venous ulcers or infected sores. 
The problem of foams is related to their very high expensiveness that does not 
allow to extend the treatment for long times, since patients have to support 
costs completely. 
Another product is “Acticoat”, an antimicrobial barrier dressing, consisting of 
an absorbent rayon/polyester core, containing silver nano-crystals. This 
product has strong antibacterial activity on the wound bed, acting in 30 
minutes (in vitro).  
However, long-term effects about biodistribution and eventual systemic 
activity of nanoparticles are unknown, as well as, this product is still too 
expensive. 
                    
Figure 4: On the left a polyurethane foam, on the right gauzes loaded with antiseptics. 
1.4 New formulations 
Novel formulations are required to overcome most of the problems of the 
devices available nowadays on the market. In this context, the present work 
focuses its attention to the use of novel technologies, proper excipients and 
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active drugs for the development of new wound healing formulations, 
administered topically, able to tailor the release of the encapsulated active 
ingredient.  
Micro- nano particulate powders able to gel in situ when in contact with the 
wound environment, are able to maximize the drug persistence in the site of 
action and to control the drug release, allowing an easy, reproducible and 
accurate administration of the loaded dose. Moreover, the use of proper 
ecceipients could promot wound healing process while stabilizing the loaded 
drug. Nevertheless, local drug administration avoids most of the problem of 
the systemic one, such as the antibiotic resistance, regarding the 
antimicrobials, which influences negatively the patients’ compliance (50). 
Such new therapeutic platforms are made by micro/nano-particulate systems in 
form of dry powders or aerogel, based on dextrans which are biocompatible 
and biodegradable, able to gel in presence of wound exudate, useful to treat 
chronic wounds, able to maximize the effect of the incapsulated model drug 
(i.e. antinflammatory, antimicrobial, wound healing promoter). Furthermore, 
some excipients chosen are able to stimulate the wound healing by theirselves, 
giving a synergic effect with the encapsulated active molecule. Gelling only 
on the lesion and not on the perilesional skin, the formulations permit to avoid 
the adverse effects of conventional medical devices, nowadays on the market, 
characterized by traumatic removal, giving, at the same time, wound 
protection from external environment and further infections.  
An aerogel is a type of material derived from a gel in which liquid has been 
substituted by a gas, generally air. They are obtained from hydrogels by a 
supercritical drying process that preserves the original gel nanostructure due to 
near zero surface tension of the solvent mixture (51, 52). 
Aerogels can be used in different field, for example for catalysis, chemical 
separation processes and to capture pollutants in waste water (53). 
Nevertheless, the typical open pore structure and high surface area make them 
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promising carriers for drug delivery as well as for the so called TERM (Tissue 
Engineering and Regenerative Medicine) (54). Because of the high 
mesoporosity of this kind of material, it is possible obtain the cell growth in it, 
with many biomedical applications. The assessment of the biological 
performance, attributed to the presence of calcium in the matrix, showed that 
the aerogels do not present a cytotoxic effect and the cells are able to colonize 
and grow on their surface.(55).  
Regarding their use in pharmaceutics, the peculiar nanoporous aergel structure 
is able to entrap large quantities of drugs, permitting to obtain formulation 
with high encapsulation efficiencies. Furthermore, this peculiarity can be 
useful in for wound healing applications, due to the ability to absorb large 
quantities of exudates.   
1.5 Polymers for pharmaceutical applications 
Synthetic and natural-based polymers have found their way into the 
pharmaceutical and biomedical industries and their applications are growing at 
a fast pace. 
Particular attention has recently been paid to chemistry of biocompatible and 
biodegradable polymers, because they have an advantage of being readily 
hydrolyzed into removable and non-toxic products, which can be subsequently 
eliminated by metabolic pathways. Furthermore, the biomedical polymers 
have to be synthesized now using friendly for the environment and safe for 
human health, effective natural initiators, co-initiators and/or catalysts (56). 
Other peculiarities are their covering power, elasticity, chemico-physical 
stability and resistence to mechanical stress. 
Materials generally used for the development of controlled release 
formulations are: 
 Cellulose derivatives: semisyntetic polymers obtained by alchilation 
and esterification reactions of ossidrilic groups of cellulose polymeric 
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chain. There are different types that differentiate by the substituent 
linked to cellulose structure. For modified drug release formulations 
for oral delivery, the most intersting are hydroxipropylmethylcellulose 
(HPMC), cellulose acetatephtalate (CAP), because of their insolubility 
at acid pH, but solubility at intestinal pH (6.8). 
 Chitosan: natural polysaccaride, constituited by glucosamine and N-
acetyl glucosamine units, linked by β (1-4) bonds, extracted from 
shellfish. This polymer is able to gelify in presence of tripolyphosphate 
solutions, by an ionotropic mechanism, by an ionic bond between 
ionized species. It can be used for oral drug release controlled system 
(57), as well as for wound healing applications, particularly low 
molecular weight chitosan, due to its intrinsec ability to induce 
macrophages proliferation by a mechanism described in literature (58). 
 Pectin: natural polysaccaride constituted by D-galatturonic acid units 
linked by α-(1-4) bonds. It gelifies ionotropically in presence of 
bivalent cations and to resist to gastric hydrolysis. It has been proposed 
for colonic delivery (59), because specific enzymes of intestinal colon 
flora, the pectinases, promote drug release from polymer. Furthermore, 
specific pectins (low methoxyl degree, high amidation degree) are able 
to gelify very quickly in presence of liquids, as well as of exudates 
(60). 
 Alginate: is a linear copolymer composed by β-D–mannuronic acid and 
α-L–guluronic acid, extracted from differen species of brown algae 
such as Phaeophycaceae, able to gelify ionotropically in presence of 
bivalent cations as calcium, forming a typical harsh structure, defined 
“egg box”, very useful for controlled drug release profiles formulations 
or for biomedical applications. High mannuronnic alginate induces 
cytokines production from human monocytes, a useful intrinsec 
activity in wound healing (61). 
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 PLGA is a biodegradable polymer belonging to block copolymers 
class, constituted by poly-lactic and poly-glycolic acids chains. With 
respect to the nature and to the strength of chains, it is possible to 
foresee the drug release kinetic. This polymer category is widely used 
for the formulation of injectable micro-particulate systems. 
PLGA micro-nano particles can be obtained with different 
methodologies, particularly “solvent evaporation” that is able to 
produce controlled drug releae systems for different route of 
administration (62). 
 PLA is a polymer of lactic acid. It exists in two enantiomeric forms (L-
D), but only L-enantiomer gives the polymeric crystal, with melting 
temperature at 180°C. PLA is a synthetic, environmentally degradable 
polymer, used in biomedical applications for more than ten years. 
It is derived from renewable resources such as corn, and it is 
hydrolytically degradable, with the products formed being 
bioenvironmentally compatible (63). 
 Poly-ɛ Caprolactone is a biodegradable polyester prepared by ring 
opening polymerization of ɛ-caprolactone using stannous octoate as 
catalyst. It has a melting point of 60°C, and it is frequently used for the 
manufacture of polyurethanes. 
Polyesters prepared by ring opening polymerization of lactones are 
intrinsically different from conventional polyesters. Depending on the 
distance between the ester groups in the chain and their interactions, it 







1.6 Encapsulation technologies  
Different novel encapsulation techniques can be applied to formulate properly 
many kind of drugs to obtain controlled drug release topic devices, also using 
one-step processes, leading to the final products ready for use.  
Furthermore, the abundance of different methodologies and excipients allows 
the production of formulation suitable for every route of administration. Micro 
and nano-encapsulation are fundamental for the manufacture of controlled 
release systems, to obtain an immediate, delayed or prolonged drug release in 
a specific body compartment.  
1.6.1 Supercritical based technologies 
In the last few year, new discoveries in supercritical fluids technology have 
allowed to increase the processes based on supercritical CO2 (SC-CO2). 
Conventional supercritical technologies are based on different mechanisms, 
such as CO2 depressurization and expansion (rapid expansion of supercritical 
solutions-RESS) or supercritical antisolvent precipitation (supercritical 
antisolvent-SAS, solution enhanced dispersion-SEDS, or aerosol solvent 
extraxtion system-ASES). 
In addition to conventional SC-CO2 extraction and separation process, applied 
particularly in food technology, new techniques such as Supercritical 
antisolvent extraction (SAE) or Supercritical Assisted Atomization (SAA) are 
gaining much interest in drug delivery. Both such techniques have been 
proposed recently in production (SAA) or curing (SAE) of particle system in 
form of dry powders or aerogel, and in this work they were compared to 
traditionals, as mini spray drying, and to the innovative nano spray drying. 
Also supercritical solution impregnation (SSI) was proposed as innovative 
method to load different drugs in polymer matrix. 
Supercritical fluids (SCF) are obtained reaching critical pressure and 
temperatures of determined substances. SCFs show liquid-like densities with 
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gas-like transport properties and solvent power that can be continuously 
adjusted by changes in pressure and temperature (65). Due to the possibility to 
use them in place of organic solvents, SCFs have many applications in 
industry. The graph below shows the phase diagram for one-component 
system. 
 
Figure 5: State diagram of carbon dioxide 
Above Critical temperature (CT) and Critical pressure (CP), specific for every 
substance, it’s not possible to distinguish liquid and vapour phase, and the 
system shows intermediate properties between liquid, as density, and gas, as 
diffusivity and viscosity (66).  
The possibility to modulate density varying temperature and pressure at 
critical point, makes SCFs versatile for different uses such as the extraction of 
components from natural materials, micronization, chemical reactions, and 
synthesis of aerogels and aerogel based composites (67). 
 Sometimes, critical temperature of some substances are too high for 
pharmaceuticals. The higher the molecular weight, the polarity and the 
intramolecular bonds, the higher CP and CT (68). Carbon dioxide is the most 
important fluid in this field, due to its safety, availability, non toxicity and low 
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cost; nevertheless, it’s easy to reach the critical pressure and temperature (CT 
31°C; CP 73.8 bar).  
The SCFs properties are known since 1897 when Hannay e Hogart (69) 
reported the first results regarding solid solubilization using high pressure gas. 
However, the first concrete applications appeared only in 1970s. Their 
properties such as the possibility to solubilize many substances optimizing the 
process conditions, make them very versatile. Supercritical processes can be 
used in place of old technologies, evaluating their many advantages also 
related to the mild conditions applied (minimization of thermic degradation of 
labile drugs, non toxic fluid, low costs, easily scalable and green processes).   
1.6.1.1 Supercritical Antisolvent Extraction 
Supercritical antisolvent extraction (SAE) is an innovative process based on 
supercritical CO2, that makes possible the extraction of many components, 
such as catechins, polyfenols from a natural matrix (coffee beans, seeds, 
berries) using a co-solvent as ethanol or acetone, with very high yields and 
without any solvent residues. 
SAE was also proposed as curing method (also named “supercritical drying” 
in this text), by a modification of the apparatus scheme, to remove organic 
solvents from solid formulations in order to obtain aerogel from alcolgel. The 
problems of conventional evaporation/extraction are avoided using SC-CO2 
because of its negligible surface tension. Because this fluid has no affinity for 
water and it is not able to extract it, it is necessary to replace aqueous medium 
with an organic solvent as ethanol or acetone (70). This procedure, named 
solvent exchange, requires a few hours before supecritical process, obtaining a 
complete solvent elimination. 
During the process, a supercritical mixture of SC-CO2 and the cosolvent is 
formed, permitting to extract liquid completely in a system with negligible 
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surface tension. These conditions, allow to maintain the nanostructured gel 
network, avoiding matrix collapse (71). 
Alginate gelifies in presence of calcium cations giving ionotropic gelation 
that makes possible the formation of the so called “egg box” (72). Substituting 
water with absolute ethanol before supercrtical process (73), it was obtained 
an alcolgel that could be processed with SC-CO2.  
The first step consists on putting the material to be processed into the vessel 
of the apparatus with a proper quantity of ethanol, close ermetically all the 
plant and set temperature at the optimized value. Then it is necessary to wait 
until temperature is reached, and then CO2 is pumped into the vessel to reach 
the desired pressure. At the end of the extraction process, conducted with a 
continuous flux of CO2 in the system, the organic solvent is completely 
separated from the dried polymer matrix. 
1.6.1.2 Supercritical Assisted Atomization 
 Supercritical assisted atomization (SAA) is one of the most efficient 
micronization technique based on supercritical CO2, which principle is the 
formation of solvent plus solid solution that are contacted with supercritical 
CO2 to form an expanded liquid of reduced viscosity and surface tension (74). 
These conditions produce an improved atomization. By the use of this 
technique it is possible to obtain microparticles in form of dry powder from a 
solution/dispersion. Schematically, two pumps are utilized, one for the SC-
CO2 and one for the processing solution. SC-CO2 is pumped into the 
pressurized chamber reaching the supercritical condition. Stainles steel 
elements allow the contact between SC-CO2 and the processing solution. A 
nozzle divides the pressurized chamber from the one at atmospheric pressure. 
A filter on the bottom allows the powder deposition. A N2 heated flux is sent 
into the chamber. 
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The expanded liquid formed in the pressurized chamber sprayed through a 
micro-nozzle. The droplets formed through the nozzle are called primary and 
they still contain SC-CO2. When they arrive in the atmospheric pressure 
chamber, the CO2 becomes gas again, causing the breaking of the primary 
droplets in to secondary of controlled dimension. The evaporation of the 
solvent is also obtained by the pre-heated N2 flow in the same chamber, and a 
filter at the bottom of the system allows the powder collection. This technique 
is versatile and suitable for many conditions. Differently from other SC-CO2 
based techniques in which water is not exploitable, SAA allows the processing 
of water based solution, and the manufacture of thermolabile pharmaceutical 
products by little apparatus modifications. 
1.6.1.3 Supercritical Solution impregnation 
The conventional preparation of drug/polymer composite is to suspend a drug 
into a polymer solution (75) but there are some problems related to this 
method such as heterogeneous drug incorporation, undesired drug reaction and 
low processing efficiency (76). 
Supercritical solution impregnation (SSI) is an innovative method to obtain 
drug loaded formulation of insufficiently soluble in water active molecules 
(77), by dissolving drugs into SC-CO2 forming a binary mixture drug/ SC-CO2 
that enhances the mass transfer in the drug loading process (78). After 
depressurization, the drug is entrapped in matrices, and finally homogeneous 
drug-loaded polymer matrices would be obtained. This technique is suitable 
for pharmaceutical, biomedical, cosmetics and food applications, as the final 
products are solvent free. 
This method is reported for the loading of norfloxacin in contact lenses (79) or  
for the preparation of flurbiprofen in PMMA-EHA-EGDMA for ophthalmic 




SSI allows to control the drug loading by the modification of some process 
parameters as well as the depressurization rate (82). 
 
1.6.2 Prilling 
Prilling or laminar jet break-up is a mild encapsualtion technique based on the 
principle of the laminar jet break-up, which is the breaking of a fluid in a 
laminar flow rate, under the action of a vibration frequence. It allows the 
production of particles with desired diameter and in narrow size distribution 
using room temperature and atmospheric pressure. 
The longitudinal vibration is obtained by a radio frequence applied on a 
nozzle of dimension ranging from 200 to 600 µm. When the vibration 
wavelenght reachs the critical value, called Rayleigh wavelenght, the fluid is 
broken in droplets that become spherical by the action of surface tension. 
During their formation, droplets fall in a cationic gelling solution (CaCl2), 
forming hydrogel with high encapsulation efficiency (83, 84). 
This technique allows the formulation of also core/shell particles, by a 
change in the nozzle configuration. Using two concentric nozzles, it is possible 
to process, one step, two different polymeric solutions. 
Laminar jet break-up has been studied since the end of 1800s by Savart 
(1833) and Magnus (1855) who showed that a stationary vibration can break 
precisely a liquid jet coming from a circular tube.  
The most important study was the linear stability analysis by Rayleigh (1879); 
he analyzed the breaking of liquid jet in air studying theoretically its instablity. 
According to these studies, instability depends on the variability of surface 
tension during the vibration. The most important application of this technique 





Figure 6: The Nisco var. D encapsulator 
1.6.3 Spray drying techniques 
Spray drying is a consolidate well known process. It is used all over the world 
in both chemical and food industry, for the production of hundreds of 
products. Starting from liquid solutions, it is possible to produce stable dry 
powders, with different applications. Also thermally sensitive material, such as 
pharmaceutical products, can be processed. Air is the heated drying medium; 
however, if the liquid is a flammable solvent such as ethanol or the product is 
oxygen-sensitive, then nitrogen is used.  
1.6.3.1 Mini Spray drying 
Mini spray drying Buchi B-191 has been used for the lab-scale production of 
dry powders, for both food and pharmaceutical application and its functioning 
can be outlined taking into account the conventional spray drying process. 
Typically, it can be divided in four fundamental steps: 
 (a) atomization of feed into a spray, (b) spray–air contact, (c) drying of 
droplets, and (d) separation of dried product from the drying air (85).  
A liquid feed solution is atomized into a spray of fine droplets into the drying 
chamber where they are in contact with hot gas at proper temperature for the 
moisture evaporation. As the moisture evaporates from the droplets, the solid 
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product is formed, and the powder is readily recovered from the drying gas. A 
cyclone separator is used as powder-collection equipment, in which particle-
laden gas enters a cylindrical or conical chamber tangentially at one or more 
points and leaves through a central opening at the top. Solid particles, by 
virtue of their inertia, move toward the wall of the separator from which they 
are led into a receiver. Working essentially as a settling chamber, the cyclone 
uses centrifugal acceleration to replace gravitational acceleration as the 
preparation (86, 87). Powder collection by the cyclone is governed by a 
complex fluid dynamic behavior in the cyclone and the receiver (88). The fluid 
behavior is affected by cyclone design (89). 
  
Figure 7: Mini spray drier Buchi B 191 and the internal parts of the atomizator. 
1.6.3.2 Innovative Nano spray drying 
Nano spray drying technology is an evolution of the spray drying and has 
been used for the production of nanometric particles as novel drug delivery 
system for different route of  administration (90, 91).  
Nano spray Buchi B-90 uses a different atomization method, based on a 
piezoelectric crystal driven actuator, vibrating a thin, perforated, stainless steel 
membrane in a small spray cap. The perforated membrane has a precise 
dimension of 4 μm, 5.5 μm or 7 μm mesh sizes that can be used to tune the 
average droplet size. The liquid feed based on aqueous or organic solvents, is 
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fed through a peristaltic pump, at the desired flow rate. When an ultrasonic 
frequence (60 kHz) is applied on the piezoelectric system, the nozzle mesh 
vibrates upwards and downwards, generating the feed droplets with very 
narrow size distribution (92). A drying gas, generally air, enters in laminar 
flow from the top into the drying chamber and is heated up to reach the set 
inlet temperature. The laminar flow is generated by air passing through a 
compact porous metal foam; laminar flow allows a gentle heating, making the 
system ideal for heat-sensitive materials. 
       
Figure 8: Nano spray drier Buchi B-90 and a schematic representation of the vibrating 
nozzle membrane. 
Particle collection mechanism is indipendent of particle mass and it’s obtained 
by an electrostatic precipitator. The vertical configuration of the spray dryer 
reduces particle adherence to the glass of the chamber, increasing collection 
yields. Prior the collection the solid particles are electrostatically charged and 
deposited at the surface of the collecting electrode consisting of a grounded 
star electrode (cathode) and cylindrical particle collecting electrode (anode). 
The presence of a high voltage around the particle collector creates an 
electrostatic field that accelerates the deposition of negatively charged particle 





Figure 9: The Nano spray drier electrostatic particle collector: On the left clean and 






















1.7 Aims of the thesis project 
The worldwide problem of complicated chronic skin wounds focuses the 
scientific community interest on the research of innovative and appropriate 
solutions, potentially able to reduce hospitalization and to replace the 
expensive treatments nowadays available on the market.  
In this context my Ph. D. project proposes the production of novel in situ 
gelling formulations based on natural biopolymers able to control drug release 
profiles and to overcome many problems related to conventional devices 
(traumatic removal, poor conformability, occlusiveness, high costs).   
High M content sodium alginate, low molecular weight chitosan, and pectins 
were chosen as biodegradable and biocompatible drug carrier. Alginate and 
chitosan are known for their intrinsic activity in wound healing as well as for 
technological characteristics, such adesivity, fluid uptake ability very useful in 
topic administration. Differences between the pectins chosen in terms of fluid 
uptake and swelling rate were considered important for the development of a 
proper novel medical device for wound healing. 
Objective of my study was to verify these properties and the processability of 
such materials with the innovative techniques proposed.  
Antibiotics such as gentamicin, doxycycline, norfloxacin were chosen to act as 
antimicrobial agent in infected wounds and to enhance the healing process by 
contrasting bacterial spreading. In fact, all the proposed antimicrobials have a 
wide spectrum of action, are inexpensive and are easily available, and their 
systemic side effects are well known. Ketoprofen was used as antinflammatory 
model drug belonging to class II BCS, while the peptidomimetic, Ac2-26 
Annessin 1 N-terminal residue, was chosen due to its ability to repair 
membrane, to organize cytoskeleton and to promote migration, all activities 
enhancing wound healing, and because it is unstable at normal physiological 
conditions. The aim was to verify the possibility to encapsulate efficiently 
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these active ingredients by novel encapsulation technologies as spray drying 
and SC-CO2 based techniques, to improve their stability after the 
encapsulation, to increase their efficiency in wound healing treatments by 
improving their bioavailability and to obtain novel formulations with tailored 
drug release profiles. 
The project proposed to study the feasibility Nano spray drying and 
supercritical CO2 based technologies such as Supercritical Assisted 
Atomization (SAA), Supercritical Antisolvent Extraction (SAE), Supercritical 
Impregnation and the tandem technique prilling/SAE. 
Important objectives were to optimize process parameters, in order to obtain 
high yields, reducing processing times and to produce successfully drug 
loaded devices in form of dry powders and aerogel.  
General objectives were to produce formulations easy to handle and 
administer directly on the wound, with rapid gelation and a proper 
transpiration and moisture control on the wound site. Moreover, a tailored 
drug release profile was mandatory. Then, all the studies were carried out in 
order to understand the formulations’ behaviour in vitro and ex-vivo, 
particularly using scanning electron microscopy, laser scattering and 
fluorescence microscopy for morphological characterization; the optimization 
of drug release profiles using Franz type diffusion cells was conducted in 
simulated wound fluids as acceptor solutions; the characterizations in terms of 
adhesiveness and transpiration properties of the formed gel, of flowability of 
the producted powders, and of gelation rates were carried out with proper 
experiments. 
In vitro tests were selected for the antimicrobial loaded formulations on 
bacterial strains; ex-vivo and in vivo experiments were carried out to 




During the last year, three months were spent in Spain at Universidade de 
Santiago de Compostela, with the aim to study an innovative supercritical 
process, the superitical impregnation, for the production of norfloxacin and 
ketoprofen loaded alginate aerogels. Objectives were to optimize process 



















































































In this work, many polymeric materials were used as carrier and different 
molecules as active pharmaceutical ingredients, as reported below: 
1) Sodium Alginate, high M residues content, high viscosity from brown 
algae- (1% viscosity 65 mPa s; mannuronic acid content 70%- Carlo 
Erba reagents, Milan, Italy) 
2) Sodium Alginate, high M residues content, medium viscosity- 
(mannuronic acid content 70%- Dompè Pharma, L’Aquila, Italy) 
3) Chitosan low molecular weight- (Sigma Aldrich, Milan, Italy) 
4) Pectin low methoxyl degree from citrus fruit, Fluka- (Sigma Aldrich, 
Milan, Italy) 
5) Pectin high amidation degree- (Herbstreit&Fox Corporate group, 
Neuenbürg/Württ, Germany) 
6) Gentamicin sulphate- (Sigma Aldrich, Milan, Italy) 
7) Doxycycline Hiclate- (Unione Commeriale Lombarda, purity ≥ 98%) 
8) Norfloxacin- (Carbosynth, Compton- Berkshire, UK) 
9) Ketoprofen- (Dompè Pharma, L’Aquila, Italy) 
10) Annessin like derived peptide, Ac2-26- (Tocris Bioscience, Bristol, 
UK) 
11) Calcium chloride, (Sigma Aldrich, Milan, Italy) 
12) Ethanol 96° and absolute, VWR and Fluka reagents (VWR 
International, Radnor, Pennsylvania, and Sigma Aldrich, Milan, Italy) 
13) KBr FT-IR degree (purity >99%trace metal basis), (Sigma Aldrich, 
Milan, Italy) 
14) CO2 (purity 99%) Società Ossigeno Napoli (S.O.N., 104 Naples, Italy). 
15) Simulated wound fluid (SWF) consisting in 50% foetal calf serum 
(Sigma Aldrich, Milan, Italy) and 50% maximum recovery diluent 
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(Sigma Aldrich, Milan, Italy), composed by 0.1% (w/v) peptone, peptic 
digest of animal tissue, and 0.9% (w/v) sodium chloride). 
2.2 Encapsulation technologies systems 
2.2.1 Prilling 
Prilling instrument used in this work is from Nisco Encapsulator® var. D 
(Nisco Engineering Inc., Zurigo CH). 
The apparatus is composed by: 
[1] A control unit regulating frequence, vibration amplitude, feed solution 
flux, stroboscopic lamp intensity.  
[2] A head containing a membrane vibrating system, used at proper 
frequency (Hz).  
[3] A stainless steel nozzle with different diameters ranging between 
100μm and 600μm; for this work 400 and 600 μm were chosen.  
[4] A 60 ml syringe containig the feed solution (polymer and drug) to be 
processed.  
[5] A piston pump (Model 200 Series, Kd Scientific Inc., Boston, MA, 
USA) used to regulate the feed solution flux.  
[6] A becker containing the gelling solution.  
[7] A magnetic stirrer.  
 
Figure 10: A schematic representation of Prilling apparatus. 
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2.2.2 Minispray drier 
The model of instrument used is Mini-spray drier Buchi-B 191(Buchi 
Laboratoriums-Tecnik, Flawil, Switzerland). This apparatus includes: 
1) A peristaltic pump for the feed delivery to the drying chamber and a 
spray gas connection to the atomizator. 
2)  A concentric nozzle for the pneumatic atomization, of 0.5 mm of 
diameter. 
3) A pre-heated drying gas entrance in co-corrent. 
4) A drying chamber in which feed droplets are transformed in dried 
particles.  
5) Two collectors, one at the bottom of the drying chamber for liquid 
droplets, one at the bottom of cyclone for dried product. 
6) A cyclone for the separation of the air from the particles to obtain the 
powder collection. 
7) A filter at the end to purify air from particulate before the 
reintroduction.  
 
Figure 11: A schematic representation of mini spray drier components. 
40 
 
2.2.3 Nanospray drier 
The model of instrument used is Nano spray drier Buchi B-90 (Buchi 
Laboratoriums-Tecnik, Flawil, Switzerland). This apparatus includes: 
1) A pre-heated gas entrance in co-corrent, on the top. A compact porous 
metal foam produces the laminar flow. 
2) A piezoelectric actuator set at 60 kHz that produces feed atomization. 
3) A drying glass chamber, in which feed droplets become dry.  
4) An electrofilter for particle collection on the bottom of the system. 
5) A grounded electrode. 
 
 
Figure 12: A schematic representation of Nanospray drier components. 
2.2.4 SAA apparatus 
The implant scheme for supercritical assisted atomization includes different 
parts: 
1) Two peristaltic pump (mod. 305, Gilson, Middleton, MO, USA), one 
for the feed solution delivery and one for the carbon dioxide which rate 
is regulated by the gas-liquid ratio. 
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2) A mixing chamber (saturator- internal volume 25 cm3), in which 
stainless steel perforated saddles make possible a large contact between 
feed solution and SC-CO2. This is the only implant part at high 
pressure values (80-100 bar), in which carbon dioxide becomes 
supercritical. This mixing chamber is linked to the precipitation one by 
an 80 µm nozzle. 
3) Precipitation chamber is heated by electrical resistances and it is at 
atmospheric pressure. Furthermore, a controlled flow of N2 was taken 
from a cylinder, heated in an electric heat exchanger (mod. CBEN 
24G6, Watlow, St. Louis, MI, USA) till 85°C and sent to the 
precipitator to facilitate liquid droplets evaporation. 
4) A filter on the bottom permits to collect powder and the gas stream out. 
 
 
Figure 13: A schematic representation of SAA apparatus. 
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2.2.5 SAE apparatus 
Supercritical drying was conducted using a laboratory implant showed in 
figure 14. 
It can be divided in three sections: 
 Pumping;  
 Drying;  
 Separation.  
 
 
Figure 14: A schematic representation of SAE apparatus. 
Pumping section is composed by: 
1) Feed line linked to a stock eservoir of 40 liters.  
2) A cooling bath;  
3) A membrane pump (Milton Roy mod. Milroyal B), modified using a 
cooling circuit of the pump head and of the CO2 aspiration line.  
Drying section includes:  
4) An owen heated by convective air;  
5) A micrometric valve allowing the CO2 entrance into the drying vessel;  
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6) A drying cilindric stainless steel (AISI 316) vessel;  
7) A micrometric valve (Hooke mod.1335G4J) at the dryong vessel exit;  
8) A three direction valve (Whithey mod. SS43S4), as a security device;  
9) A back pressure valve (Tescom mod. 26-1700), at the end of the separator;  
10) A rotameter (ASA mod. N.5-2500, Serval N.115022), for measuring the 
instant CO2 flow;  
11) A roll counter measuring the total CO2 quantity flowed (Sim Brunt, mod. 
B10). 
Separation section includes:  
12) A conic stainless steel separator (inox AISI 316);  
13) An on/off valve (Whithey mod. SS43S4), put on the separator bottom, that 
allows to withdraw solvent during the process;  
14) A glass flask to collect solvent extracted.  
Drying implant include salso manometers to measure pressures, termocouple 
to control operative temperatures. All the controls are localized in a specific 
electric panel. 
2.2.6 Supercritical impregnation apparatus 
Supercritical impregnation apparatus scheme is showed below. 
 
Figure 15: Scheme of Supercritical Impregnation apparatus. 
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The apparatus is composed by a bottle containing CO2 (T1) which flux is 
controlled by valve V1. 
 Then CO2 is conducted to peristaltic pumps (P1) cooled by a bath (Ex1). 
 A series of valve (V2, V3, V4) serves to regulate pressure along the tubes that 
conduct to the vessel (Re1). 
 Into the vessel pressure is increased at the desired value and temperature is 
regulated by termocouples associated to electric resistences.  
Valve V5 is at the end of the apparatus to depressurize easily the vessel. 
A back pressure valve, controlled by a software, is needed to perform a precise 
depressuriation program. 
2.3 Analytical technologies 
2.3.1 FT-IR spectroscopy 
Infrared analysis was performed using a FTIR spectrophotometer (FT-IR 
Nexus, Thermo-Nicolet, West Palm Beach, FL, USA) equipped with a 
mercury-cadmium-telluride detector. This analysis was used for powders as 
well as for aerogel beads. The samples were combined with small amount of 
potassium bromide FT-IR degree (with ratio sample/KBr from 1/20 to 1/60, 
depending on the flowability of the powder analized) and pressed from 6 to 10 
tonnes in a manual press (OMCN s.p.a., Bergamo, Italy). The thin compacts 
produced were analyzed using 256 scans with a1 cm−1resolution step.  
 
Figure 16: FT-IR Nexus apparatus. 
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2.3.2 Differential Scanning calorimetry 
Beads, dry powders and raw materials thermal characteristics were determined 
by differential scanning calorimetry (DSC) (Mettler Toledo DSC 822e module 
controlled by Mettler Star E software, Columbus, Ohio). An appropriate 
amount of dried beads or powders was crimped in a standard aluminum pan 
that was pierced and heated from 25°C to 130°C firstly to obtain dehydration 
and then from 25°C to 350°C at a scanning rate of 10°C/min to perform the 
analysis. The characteristic peaks were recorded and the specific heat of the 
melting endotherm was evaluated. DSC was performed in nitrogen atmosphere 
at a flow rate of 100 mL/min.  
 
Figure 17: DSC 822e Mettler Toledo apparatus. 
2.3.3 Scanning Electron Microscopy 
The morphology of all formulations, studied by Scanning electron microscopy 
(SEM), was performed using a Carl Zeiss EVO MA10 microscope with a 
secondary electron detector (Carl Zeiss SMTLtd., Cambridge, UK) equipped 
with a LEICA EMSCD005 metallizator producing a deposition of a 200–400 
Å thick gold layer. Analysis was conducted at 20 KeV. Powders were 
dispersed on a carbon tab previously stuck to an aluminium stub (Agar 
Scientific, Stansted, UK). Samples were coated with gold using a sputter 
coater (mod. 108˚A, Agar Scientific, Stansted, UK). At least 20 SEM images 




Figure 18: Scanning Electron microscope Evo Zeiss MA 10. 
2.3.4 Laser Scattering 
Particle size distribution was evaluated by static light scattering (LS) equipped 
with a microliquid module (Coulter LS 13320, Beckman Coulter, Inc., 
Fullerton, CA, USA). The Coulter LS 13320 software uses Mie theory to 
produce an optimal analysis of the light energy distribution and to obtain the 
size distribution of the particles. Analyses were performed after the 
preparation of the microspheres suspensions using 30 mg of each sample 
dispersed in dichloromethane by sample sonication. The effectiveness of the 
microspheres dispersion was verified performing the measurement after 
different sonication times ranging between 5 and 30 minutes. Moreover, 
measurements on each sample loaded in the instrument were repeated at 
different time intervals, that is, every 5 minutes for 30 minutes. Results were 




        (1) 
where d90, d50 and d10 indicate the volume diameters at the 90th, 50th and 10th 





Figure 19: Beckman Coulter LS 13320 apparatus. 
2.3.5 Adhesion strength mesuarments 
Adhesive properties of the formulations were evaluated by means of a tensile 
stress tester Electroforce 3200 testing instrument (Bose, Eden Praire, MN) 
using a modified protocol of ASTM D3808 standard. Briefly, each 
formulation (15 mg of dry powder) was layered on a nitrocellulose membrane 
filter (0.45 µm pore size, 3.14 cm2 area) conditioned with SWF. After gel 
formation due to the contact between the formulation and the fluid, reached in 
30 min, the membrane was placed on the movable horizontal sample-holder of 
the apparatus. The movement of the sample holder at a rate of 1 mm/min 
caused the compression of the gel against the measuring head of a calibrated 
load cell. The force time curve was recorded on a personal computer and the 
force under which gel detached from substrate was calculated by LabChart 8 




Figure 20: Tensile stress tester Electroforce 3200 Bose, Eden Praire. 
2.3.6 Density measurements 
A Helium pycnometer (Accupyc 1340, Micromeritics Corporate, Norcross, 
USA) was used to study the real density of the powders produced with 
different polymers. 
 
Figure 21: Micromeritics Accupyc 1340, helium pycnometer. 
A calibration program was performed, in order to have optimal results. 
 For analysis, it was firstly necessary to set the regulator pressure of helium at 
the higher (plus 2 psig) of the purge fill pressure and the cycle pressure. By 
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opening and close the valves, it was possible to equilibrate helium flux into the 
measurement chamber. 
Then, a powder amount of about 150-200 mg was put into a sample cup 
previously dried, and the weight recorded. When the sample was loaded, the 
cup was immedialtely replaced on the holder, in order to prevent particles 
from accumulating on the greased.  
Ten measurements were performed and an average value was calculated. 
2.3.7 Pore volume measurements 
Brunauer Emmett Teller theory explains the physical adsorption of gas on 
solid surfaces and it is the basis to measure specific surface area of a material. 
 Physical adsorption results from relatively weak forces (van der Waals forces) 
between the adsorbate gas molecules and the adsorbent surface area of the 
material. 
Specific surface area of the alginate aerogels was quantified from low-
temperature N2 adsorption-desorption data (Nova 3000e, Quantachrome, 
USA). Prior to measurements, samples were dried for 20 h under vacuum (<1 
mPa) at 60°C for the outgassing phase. This procedure is useful to remove 
gases and vapours that may have become physically adsorbed onto the surface 
after manufacture and during treatment, handling and storage. 
The determination was usually carried out at the temperature of liquid 
nitrogen. The amount of gas adsorbed can be measured by a volumetric or 
continuous flow procedure. In this work, a static volumetric determination was 
conducted. As adsorption takes place, the pressure in the confined volume falls 
until equilibrium is stablished. The amount of gas adsorbed at the equilibrium 
pressure is given as the difference between the amount of gas admitted and the 
amount of gas required to fill the space around the adsorbent, the dead space, 





Figure 22: Nova 3000e, Quantachrome, USA- Brunauer Emmett Teller measurements. 
2.3.8 Polymer solutions rheological characterization 
Polymer solutions, of the Ac2-26 loaded hydrogel, were subjected to a 
complete rheological characterization using a rotational rheometer (Bohlin CS 
Rheometer, Bohlin Instrument Division, Metrics Group Ltd., Cirencester, 
UK). A cone plate combination (CP 4/40) was used as measuring system. All 
measurements were carried out at 37 °C, after a rest time of 3 min. Zero shear 
rate viscosity, η0, was obtained after application of 50 s
−1 shear rate for 1 min. 
Dynamic oscillatory tests were performed in the linear viscoelastic range. The 
viscoelastic parameters storage modulus (G’) and loss modulus (G’’) were 
measured at frequencies ranging between 0.1 and 5 Hz. 
  
Figure 23 Image of Bohlin CS rheometer instrument  
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2.4 Experimental procedures 
2.4.1 Powders, aerogels and hydrogels preparation 
2.4.1.1 Gentamicin, alginate and pectin powders 
Gentamicin (GS), alginate and pectin powder formulations were prepared with 
specific protocol described here. Particles obtained by nanospray drying and 
SAA (vs Mini spray drying) were prepared by processing different aqueous 
feeds. After a series of pilot experiments, GS and alginate/pectin ratio were set 
at proper values, and different total concentrations of the colloidal dispersion 
were chosen (see results and discussion 3.1.1 and 3.2.1.1). Feeds were 
obtained by slowly adding a GS solution to an aqueous solution of alginate 
and pectin blend, previously prepared, under gentle stirring. Dextrans blend 
solution was obtained by dissolving both polymers in distilled water under 
vigorous stirring while GS solution was obtained by dissolving a carefully 
weighted amount of the drug in distilled water under gentle stirring.  
Nano spray drying process parameters and conditions were set as follows: inlet 
temperature 90 °C, feed rate 9.5 ml/min; nozzle diameter 4.0, 5.5 or 7.0 mm, 
air flow 100 l/min, relative spray rate 100%. 
Feeds for pneumatic atomization were spray-dried using spray drying 
laboratory apparatus (mini spray dryer B-191 BuchiLaboratoriums-Tecnik, 
Flawil, Switzerland) with process parameters and conditions set as follow: 
inlet temperature 120°C, outlettemperature 66°C, feed rate 5 ml/min; nozzle 
diameter 0.5 mm, drying air flow 500 l/h, air pressure 6 atmospheres, aspirator 
100%. Feeds for supercritical assisted atomization (SAA) were produced using 
a laboratory apparatus consisting of two high-pressure pumps (mod. 305, 
Gilson, Middleton, MO, USA) delivering the liquid solution/suspension and 
liquid CO2 to a heated bath (Forlabmod. TR12, Carlo Erba, Milan, Italy) and, 
then, to the saturator. The saturator (internal volume 25 cm3) containing 
stainless steel perforated saddles which assure a large contact surface between 
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liquid solution and CO2. The SAA process was conducted dissolving super-
critical CO2 (SC-CO2) in the feed solutions (mass flow ratio between CO2 and 
water set at 2.5). The solution obtained in the saturator was sprayed through 
the injection nozzle into the precipitator (internal volume 3 dm3) operating at 
atmospheric pressure. A controlled flow of N2 was taken from a cylinder, 
heated in an electric heat exchanger (mod. CBEN 24G6, Watlow, St. Louis, 
MI, USA) till 85°Cand sent to the precipitator to facilitate liquid droplets 
evaporation. The saturator and the precipitator were electrically heated using 
thin band heaters. A stainless steel filter located at the bottom of the 
precipitator allowed the powder collection and the gaseous stream flow out. 
2.4.1.2 Doxycycline, alginate, chitosan and pectin powders 
Doxycycline, alginate, chitosan and pectin powder formulations were prepared 
using the protocol described as follows. 
Briefly, a proper amount of alginate was dispersed in distilled water and left 
under stirring until a homogeneous solution was obtained. In another becker 
chitosan was dissolved in HCl 0.1M and then a 50 mM solution of 
tripoliphosphate (TPP) was added in order to obtain a partial complexation of 
the polymer (93).  
Then the chitosan/TPP solution was slowly added in the alginate one, avoiding 
total precipitation. A partial precipitation happened in every case, and an 
adjustment of pH until 5.5 was required to clarify the solution and to have the 
final powder with a pH value correct for skin application (94). 
Mini spray drying parameters were 110°C of inlet temperature, 72°C of outlet 
temperature, 500/600 air flux, 6 bar of air pressure, 100% aspirator and 10% 
pump, 0.5 mm nozzle. 
Nano spray drying parameters were 70°C of inlet temperature, 65°C of head 
temperature, and 40°C of outlet, 5.5µm nozzle, 100 l/min of air flux and 30 
mbar of pressure.  
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2.4.1.3 Alginate aerogels preparation 
Optimization parameters of prilling and SAE for the tandem technique 
Prilling/SAE are described in paragraph 3.2.2.1. 
2.4.1.4 Core/shell aerogels preparation 
Core/shell particles were obtained using a specific protocol described here, 
after the optimization of Prilling/SAE tandem technique. 
Microcapsules were produced using prilling apparatus equipped with two 
syringe pumps and with coaxial nozzle which consists of two concentric 
nozzles. Alginate annular solution was pumped through a 600 µm nozzle 
while for the D/pectin core solution was used a 400 µm nozzle. The vibration 
frequency set to break up the laminar liquid jet was 350 Hz and amplitude of 
vibration at 100%. The distance between the vibrating nozzle and the gelling 
bath was fixed at 25 cm. A stroboscopic lamp set at 65% of amplitude was 
used to observe the falling droplets. Gelling solution consisted of 0.5M CaCl2 
ethanolic solutions (100% ethanol 96°), saturated with doxycycline, under 
gentle stirring in which the droplets were held for 5 minutes and then put into 
paper filters (Rishi tea, loose leaf tea bags) for the drying process without 
rinsing. Supercritical optimized conditions were 150 bar, 38°C, 0.6 kg/h CO2 
flow and the experiments last 90 minutes. 
2.4.1.5 Alginate aerogels loaded by supercritical impregnation 
In the period spent at Universidade de Compostela, the combination of 
prilling/supercritical drying/supercritical impregnation was studied. Firstly, 
alginate hydrogels were prepared by prilling using these optimized conditions 
(8 ml/min of feed flow rate, 350 Hz of frequency, 100% of amplitude and 400 
μm the nozzle diameter and 25 cm the distance between the vibrating nozzle 
and the gelling bath). Supercritical drying was conducted using conditions set 
at 120 bar, 40°C, 5-7g/min for 3.5 h. Impregnation process was conducted at 
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180 bar, 40°C in batch mode. Depressurization was conducted using a specific 
protocol in order to avoid drug amorphization (from 180 bar to 5 bar in 1.5 h 
with proper time steps: 180-160 bar in 516 seconds, 160-140 in 308 seconds, 
140-120 in 256 seconds, 120-100 in 1835 seconds, 100-80 in 586 seconds, 80-
65 in 823 seconds, 65-45 in 655 seconds, 45-30 in 221 seconds, 30-15 in 303 
seconds and 15-5 in 108 seconds). 
2.4.1.6 In situ injectable Ac2-26 hydrogels 
Alginate and chitosan hydrogels for the encapsulation of Ac2-26 Annessin 1 
like derived peptide were prepared as described below. 
Alginate powder was dispersed in distilled water under vigorous stirring (1500 
rpm) for 15 min then the solution was left undergentle stirring (100 rpm) for 2 
h. Finally, polymer solutions were left motionless for 4 h to remove air 
bubbles. Chitosan gels were prepared using the same procedure dissolving 
chitosan powder in 0.1 M acetic acid buffer solution then pH was adjusted to 
6.3 using 0.1 M NaOH aqueous solution. Ac2-26 peptide loaded gels were 
prepared by mixing in an orbital shaker (Vortex Genius 3, IKA-Werke GmbH 
& Co., Staufen,Germany) a precise volume of either high M alginate or LMW 
chitosan solution by means of an Hamilton syringe (Hamilton AG,Bonaduz, 
Switzerland) and a precise volume of a peptide stock solution by means of a 
Gilson pipet (Pipetman Classic, Gilson, Inc.,Middleton, WI, USA) in order to 
obtain a final peptide concentration of 100 nM, 500 nM and 1 µM in either 
alginate solution at 2.5%and 5.0% (w/w) or chitosan solution at 3.5% and 
6.5% (w/w). 
2.4.2 Drug permeation and fluid uptake ability studies 
Drug permeation profiles of formulations were obtained by means of Franz 
type diffusion cells using, as donor compartment, a simulated wound fluid 
(SWF) composed by 50% of Fetal Calf Serum and 50% of peptone, 0,1% 
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peptic digestic fluid and 0,9% NaCl physiological solution (95) or 100 mM 
phosphate buffer (KH2PO4) correcting pH at 7.4 with NaOH 6N  
 
Figure 24: Franz type diffusion cell and Merck Millipore HVLP membranes 
The cell was thermostated at 37°C, with 200 rpm of stirring, and the 
membrane used were of 0.45µm of diameter and HVLP (for biological 
solution, Merck- Millipore, Darmstadt, Germany) or HAWP (nitrocellulose, 
Merck- Millipore, Darmstadt, Germany) types. For drug permeation studies, 
formulation was put on the membrane, previously conditioned, and at defined 
point of time, the samples were collected by the sampling port in a quantity of 
0.2 ml and then analysed using proper methods, adapted on each molecule, as 
described afterwards.  
AC2-26 release assays were performed by means of slide analyzer mini 
dialysis units, 10 K molecular weight cut off (Thermo Fisher Scientific Inc., 
Waltham, MA, USA) with an exposed surface area of 0.33 cm2. The dialysis 
cup was filled with 200 µl of AC2-26 loaded gel. Experiments were conducted 
in a cylindrical vial filled with 3 ml of simulated wound fluid (SWF) 
thermostated at 37°C and magnetically stirred at 200 rpm by a teflon-coated 
stirring bar placed in the receptor compartment. The receptor solution, 100 µl 
aliquots, were sampled at specific time points and analysed by LC-MS for the 




Figure 25: Slide analyzer dyalisis unit 
For fluid uptake ability studies, conducted on dry powders and aerogels, Franz 
cell was used in an open configuration, without the donor chamber, and 
membrane with sample was weighted at defined point of time, in order to test 
the quanitity of fluid absorbed by the dry formulation.  




∗ 100    (2) 
where Ww is the weight of the wet formulation, and Wd is the initial weight, 
when formulation is dry. 
2.4.3 HPLC, LC/MS and Uv-vis Spectrophotometry methods for drug content 
and encapsulation efficiency determination 
Drug content (d.c.) was obtained as the ratio between actual drug weight and 
total formulation weight while encapsulation efficiency (e.e.) was calculated 
as the ratio of actual to theoretical drug content.  
Gentamicin (GS) was analysed with a modified pharmacopoeia method for GS 
and calibration curves were worked out and proportionality between GS 
concentration and AUC checked in the range 5–450 µg/ml. The isocratic 
method had as mobile phase an aqueous solution consisting in 70% Methanol, 
25% water and 5% acetic acid glacial. The column was a Macherey-Nagel 
150*4,5 mm -100/5Å. 
1 mg of powder was dissolved in 3 ml of HPLC water and left under stirring 
until a homogeneous solution was obtained. 
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Gentamicin was derivatized in order to become Uv sensible, using an orto-
phtaladialdeide solution, with the following protocol: an aliquot of 200 µl of 
sample was mixed with 2,48 ml of water, 2,75ml of isopropanol, 1 ml of 
derivatizing solution and 1 ml of mobile phase. The resulting solution, after 15 
minutes in a 61°C water bath, was then filtered with 0.45 µm filters for 
organic solvents and analysed at 340 nm. 
Doxycycline was analysed in aqueous medium at Uv-vis spectrophotometer at 
342 nm. Briefly, 3 mg of powders were dissolved in 6 ml of distilled water and 
left under stirring until complete dissolution was reached. The solution 
obtained was filtered with 0.45 µm Millipore filters and analysed using 1 cm 
quarz cells.  
The procedure for core/shell aerogel doxycycline loded particles was a little 
different: 2 or 3 beads were put in 2 ml of 100mM PBS and left under 
vigorous stirring until an homogneous solution was obtained. Then 8 ml of 
bidistilled water were added and then the solution was sonicated for 5 minutes 
and finally filtered with 0.45 µm filters.  
Ketoprofen and norfloxacin were analysed by Uv-vis spectrophotometry, 
using wavelenghts of 254 nm and 334 nm respectively, and 274 nm for the 
mixture of the two drugs. The molecules extraction procedure from aerogel 
matrix was the following. 2/3 mg of particles were put in 2 ml of 100 mM PBS 
and left under vigorous stirring until a homogeneous solution was obtained.  
 Then 3 ml of bidistilled water were added and the solution was centrifuged at 
6000 rpm for 10 minutes and then analized. If necessary, a diluition on the 
sample was performed. 
Ac2-26 HPLC-MS method used was the following: after 6 h of incubation, 1 
ml of each sample was pre-purified on a Chromabond HR-X SPEcartridge 
(Macherey-Nagel, Düren, Germany) using water and 70% acetonitrile as 
washing and elution solution, respectively. LC/MSanalyses were performed on 
a LTQ XL instrument (Thermo Scientific) equipped by an ESI ion source and 
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a hybrid quadrupole/lineartrap analyzer and coupled with an Accela 600 
HPLC system. Chromatography was performed on an Aeris C18 (2.0 × 150-
millimeteri.d., 3µm) reversed-phase column, using a mobile phases A 
(0.1%formic acid in water, v/v) and B (0.1% formic acid in acetonitrile, v/v), 
using a linear gradient increase from 25 to 70% B in 30 min. The flow rate 
was 200 µl/min. Mass spectra were acquired in positive ion mode over the m/z 
range from 700 to 1600.  
2.4.4 Fluid loss experiments 
Fluid loss of hydrogel formulations was evaluated over time as the ratio 
between fluid content of the gel at a specific time point and a carefully 
weighted amount of gel after preparation. Briefly, 250 µl of formulation was 
spread over a previously weighted filter paper disc. The membrane was in 
contact with a donor compartment filled with 100 µl of simulated wound fluid 
(SWF). 
At regular intervals of time, the weight of the gel was measured. Fluid loss 





∗ 100    (3) 
where W0 is the initial weight and Wt is the weight at the specific time point. 
2.4.5 Antimicrobial tests 
Briefly, an overnight culture of S. aureus strain A170 was diluted 30 fold with 
prewarmed Mueller-Hinton Broth (MHB) and incubated at 35°C under 
constant shaking. The late log phase of growth was normalized to 2.5 × 108 
cells/ml and 200 µl were used to inoculate three sterile 96-well plates further 
treated with the different formulations corresponding to a proper quantity of 
GS, used as control. At defined time points (6, 12, and 24 days), viable counts 
were calculated to give CFU/ml (colony forming unit per ml) by plating serial 
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dilutions on MHA incubated at 35◦C. Kill curves were plotted with time 
against the number of CFU recovered. Each antimicrobial assay was 
performed in triplicate in separate days. To assess the ability of formulations 
to degrade P. aeruginosa ATCC-27853 biofilm, bacteria were grown 
overnight in MHB medium. Cultures were then diluted to approximately 
107CFU/mL in fresh MHB medium, and 200 µl was used to inoculate flat-
bottom 96-well polystyrene microlitre plates. The biofilms were allowed to 
develop up to 24 h at 37◦C, afterwards, formulations corresponding to 0.25 or 
0.70 mg/ml of GS (for nanospray and minispray/SAA formulation 
respectively) used as control were added on each well. After incubation for 8 h 
at 37°C without shaking, the plate wells were washed twice with phosphate-
buffered saline (pH 7.2) to remove unattached cells and dried in an inverted 
position. Finally, the adherent cells were stained for10 min with 200 µl of 
Gram’s crystal violet (CV). Wells were rinsed with water and dried. The 
amount of biofilm mass was obtained by destaining the wells with 200 µl of 
33% acetic acid and then measuring theabsorbance of the CV solution in a 
microplate spectrophotometer set at 595 nm (Thermo Scientific Multiskan 
Spectrum Model 1500, Themo Scientific, Milan, Italy). 
 Disc diffusion test was carried out on MHA according to Clinical and 
Laboratory Standard Institute (CLSI) guidelines (96), with some 
modifications. Briefly, a bacterial culture of S. aureus (108 cells/ml), was 
spread by a sterile cotton swabs on MHA agar plate. Similarly, a bacterial 
culture of P. aeruginosa was adjusted to 108 cells/ml was spread on MHA 
agar plate. The plates were spotted with the different formulations 
corresponding to a proper quanityt of GS, used as control. After incubation at 
35°C for 24 h, the diameter of the zones of clearance produced by each 
powder were compared. 
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Figure 26: on the left a disc diffusion test preparation, on the right the P. aeruginosa 
biofilm degradation test. 
2.4.6 Water vapour transmission rate experiment 
Water vapour transmission rate (WVTR) was obtained as described by ASTM 
standard (ASTM Standard, 2010). Briefly, 25 mm hydrogel disc of each 
formulation was mounted on the top of a plastic tube containing 20 ml of 
distilled water. Teflon tape was used to cover the edge of the disc in order to 
avoid boundary loss. The assembly was kept inside an incubator at 37 °C. 
Weight loss was recorded at regular time intervals and plotted against time. 
WVTR was calculated as the ratio between slope of the plot and area of the 
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where A is the test area of the sample in m2. Water evaporation rate from in 
situ formed hydrogel was obtained as loss of weight over time by using the 
same procedure described above and noting the weight of the hydrogel at 
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Figure 27: Laboratory apparatus for the measurements of water vapour transmission 
rate.  
2.4.7 Flowability test 
Bulk and tap density of all powders was measured by modifying the 
pharmacopoeia test, as reported in literature (97, 98). Briefly, powders were 
loaded into a bottom-sealed 1 ml plastic syringe (Terumo Europe, Leuven, 
Belgium) capped with laboratory film (Parafilm® “M”, Pechiney Plastic 
Packaging, Chicago, IL, USA) and tapped until no change in the volume of the 
powder was observed. The bulk and tap densities were calculated from the 
difference between the net weight of the plastic syringe content divided by the 
volume in the syringe before and after tapping, respectively, obtaining the 
Hausner Index. The more this value, the lower the flowability. Furthermore, it 
depended on particle roughness and dimension. 
An index of 1.85, measured on a commercial dry powder formulation, was 
used as comparison in this thesis work. 
2.4.8 Molecular dynamic simulations 
Molecular dynamics simulations were performed using YASARA 12.7.1650 
with the NPT ensemble at 310 K and 1 atm. The YAMBER3 force field was 
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used. All simulations ran with a 1.25 fs time step for intramolecular forces and 
a 2.50 fs time step for intermolecular forces. The equilibration period was 20 
ns. 
2.4.9 In vivo experiments 
C57BL/6 mice were obtained from Harlan Laboratories (Indianapolis, IN, 
USA) and housed 4 per cage prior and 1 per cage during experiments. On the 
day of surgery, the hair on the back of each mouse was clipped, and the skin 
was wiped with ethanol. C57BL/6mice, 10 weeks of age, were anesthetized 
with isoflurane prior to the wound-creating surgery. Full-thickness excision 
wounds (1 cm × 1 cm) were created by marking the area of the wound in the 
shaved mid-back with a fine marker and a ruler, lifting the skin with a pair of a 
forceps and excising the full-thickness skin along the lines with a pair of 
surgical scissors. Immediately after the surgery on day 0, the wounds were 
topically treated with 100 µl of either 5.0% alginate gel (placebo) or the same 
gel containing Ac2-26 peptide. Penicillin (5 mg per mouse) was injected 
intramuscularly to prevent infections. 
Sixty mice were randomly divided into five groups: (1) control group; (2) 
5.0% alginate gel; (3) Ac2-26 100 nM/alginate hydrogel group; (4) Ac2-26 
500 nM/alginate hydrogel group; (5) Ac2-261 µM/alginate hydrogel group, 
twelve mice for each group. The control group was treated with 0.5 ml saline 
solution topically; the blank 5.0% alginate hydrogel group was treated with 0.5 
ml of 2.5% alginate hydrogel administered topically; the Ac2-26 loaded 5.0% 
alginate hydrogel group was treated with 0.5 ml of Ac2-26 loaded 2.5% 
alginate hydrogel (containing 100 nM, 500 nM or 1 µM of Ac2-26 peptide) 
administered topically. On 3th, 6th, 9th and 14th day of post-wounding, three 

























































































































3.1 SECTION A 








































3.1.1 Gentamicin, Alginate and Pectin Nanospray drying formulations 
In this study, feeds were processed by the novel nano spray drying technology 
to produce a nanoparticulate powder based on alginate-pectin blend loaded 
gentamicin sulphate (GS) able to gel quickly into a wound cavity. Polymeric 
blend was composed by high mannuronic content alginate, able to stimulate 
cytokine production by human monocytes very useful in wound healing 
process (61), and low methoxyl degree pectin that, in combination with 
reduced particle dimensions, is able to speed-up in situ gel forming rate. 
The encapsulation technology has been evaluated regarding its effect on yield, 
drug encapsulation efficiency, particle micromeritics, morphology and size 
distribution. 
The innovative atomization mechanism, due to a vibrating nozzle membrane 
activated by a piezoelectric crystal, and the electrostatic collector of 
Nanospray drier, make possible to obtain very low particle size distribution, 
and very high yields, despite the use of small quantities of feed solution and 
the employ of short times. 
During my first approach to this innovative technique, I studied how to 
optimize all the process parameters and the feed solution preparation steps, in 
order to achieve the best results. 
With the aim to obtain an easy in situ gelling and removable formulation for 
local antibiotic controlled release, properties related to a good wound dressing 
gel such as gelation rate, swelling, wound fluid uptake and moisture 
transmission rate were studied. 
Particles obtained by nanospray drying were prepared by processing different 
aqueous feeds. After a series of pilot experiments, GS and alginate/pectin ratio 
of 1:1:1 and total concentration of the colloidal dispersion of 0.10%, 0.25% or 
0.50% w/v were set. Feeds were obtained by slowly adding a GS solution to 
an aqueous solution of alginate and pectin blend, previously prepared, under 
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gentle stirring. Dextrans blend solution was obtained by dissolving both 
polymers in distilled water under vigorous stirring for 1 h, while GS solution 
was obtained by dissolving a carefully weighted amount of the drug in 
distilled water under gentle stirring. 
All formulations were spray-dried with the Nano Spray Dryer B-90 (Buchi 
Laboratoriums-Tecnik, Flawil, Switzerland) with process parameters and 
conditions set as follow: inlet temperature 90 °C, feed rate 9.5 ml/min; nozzle 
mesh diameter 4.0, 5.5 or 7.0 µm, air flow 100 l/min, relative spray rate 100%. 
Table 1: Yield, particle size and span, drug content, encapsulation efficiency and water 
content of all samples (from GAPNs1 to GAPNs 9). 






















4 0.1 82.4 310 (1.38) 23.9±0.3 4.2 ± 0.3 72.4±0.2 
GAPNs2 4 0.25 88.2 347 (1.46) 26.7±0.4 4.1± 0.4 80.9±0.3 
GAPNs3 4 0.5 91.9 405 (1.60) 25.4±0.2 4.1 ± 0.4 77.0±0.1 
GAPNs4 5.5 0.1 67.5 520 (2.02) 23.6±0.2 4.9 ± 0.5 70.8±0.1 
GAPNs5 5.5 0.25 72.9 551 (2.05) 26.6±0.3 5.4 ± 0.4 79.9±0.2 
GAPNs6 5.5 0.5 78.9 608 (2.12) 25.5±0.2 6.2 ± 0.4 76.5±0.1 
GAPNs7 7 0.1 65.7 852 (1.56) 27.8±0.1 7.5± 0.6 83.5±0.1 
GAPNs8 7 0.25 66.7 978 (2.01) 26.2±0.2 7.6± 0.3 78.6±0.2 
GAPNs9 7 0.5 72.9 1003 (2.46) 27.3±0.2 7.7± 0.4 82.0±0.1 
 
As showed in the table above, GAPNs series 1-3 are made with 4 µm nozzle, 
4-6 with 5.5 and 7-9 with 7 µm.  
All formulations were obtained with good production yield ranging from 65 to 
91%. The smaller the nozzle, the higher the yield. Using 4 µm nozzle is 
reduced the loss of product on the glass wall of the nano spray dryer with an 
increase in the yield. 
As expected, particles size as well as particles size distribution (PSD) 
increased with nozzle spray mesh diameter, producing particles with d50 
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ranging between 1003 (GAPNs9) and 310 nm (GAPNs1). Moreover, 
GAPNs1–3 exhibited d50 under 410 nm with span between 1.60 and 1.38. 
As a result of the optimization of parameters conducted during this work, high 
yields and very interesting particle dimension ranges, expecially for samples 
produced by 4 µm mesh nozzle, were obtained. 
PSD was also affected by feed concentration, the higher the feed concentration 
the wider the size distribution. This is explainable by the change in viscosity 
with the increase in concentration of the feed. Consequently, the droplet 
dimension increases with viscosity. 
Drug content (d.c.) and encapsulation efficiency (e.e.) were evaluated by 
means of HPLC analysis, using a pharmacopoeia modified method for the 
quantification of gentamicin (99). High encapsulation efficiency (e.e.) was 
obtained (between 70 and 83%) without any significant difference between 
formulations. However, both spray mesh diameter and feed concentration 
increased formulation water content; this effect may be explained considering 
the decreasing of surface tension of the droplets coming out from smaller 
nozzles that allows easier water evaporation (75, 100, 101). After their 
preparation, powders were chemico-physical and morphological characterized 
in order to foresee their behavior in vitro and in vivo.  
Different particle morphologies were observed in the various formulations in 
dependence on both vibrating nozzle diameter and feed concentration. 
Spherical morphology was predominant, especially when 4 µm vibrating mesh 
nozzle was used (sphericity coefficient about 0.93); wrinkled or doughnut 
shaped particles mixed with the spherical ones were observed when either feed 
concentration or mesh nozzle increased reducing sphericity till 0.83. This 
phenomenon is probably related to a change in droplet/gas contact in the last 
phases of drying process (102, 103) due to a reduction of the temperature and 




Moreover, when 7µm mesh nozzle was used (GAPNs9) large collapsed 
particles were also recognizable (Fig. 28 d) due to droplet coalescence 
occurring at piezoelectric driven spray head (104). High resolution SEM 
analyses showed that both micro and nanoparticles were composed by close-
packed colloidal particles (raspberry particles) (28f).  
 
Figure 28: a) GAPNs1 particles produced with 4 µm nozzle. d) GAPNs9 produced with 
7 µm nozzle and f) a higher magnification for particles GAPNs9 
Colloidal dispersion that originated raspberry nanoparticles is generated 
during the feed preparation by interaction between amine residues of 
gentamicin and preferentially the carboxyl groups of M residues of alginate 
that produce a polyelectrolyte complex that enhance formulation stability (as 
shown in figure 28 f) and would slow down drug release rate (50, 105). A 
good flowability in addition to favorable traspiration properties and a good 
fluid uptake ability are needed to optimize all the formulations (106). 
Flowability of the powders is, infact, a fundamental parameter that indicates 
the possibility to sprinkle them on the lesion with uniformity, obtaining a 
complete and correct covering of the wound. It was correlated to both particle 
size distribution and shape. The presence of wrinkled large particles in some 
formulations widened PSD and reduced flowability. In fact, in spite of the 
increased mean particle size, the enhancement of effective contact surface area 
between large wrinkled or collapsed particles and the smaller spherical ones 
(107) lead to lower flowability. Flowability of the powders expressed as ratio 
between tapped density (ρT) and bulk density (ρB) ranged between 2.42 and 
2.68 for 4 µm mesh nozzle whereas particles obtained by 7 µm mesh nozzle 
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demonstrated a ρT/ρB ranging between 3.33 and 3.89, in accordance with 
increased feed concentration. In this work, the value of ρT/ρB ratio for a 
commercial formulation of 1.85 was used for comparison purposes. 
Fluid uptake ability of the powders was evaluated as the ratio between the 
weight of the formulation after in situ gel formation due to contact with 
simulated wound fluid (SWF) and initial dry state. SWF uptake was very fast; 
all the formulations moved completely from powder to gel state within 15 min 
where they reached the maximum swelling followed by an equilibrium phase. 
Swelling rate was directly correlated to particle size, resulting in the fastest 
swelling kinetic for GAPNs1 that needed 10 min to move into hydrogel state.  
Because of GAPNs series should provide an adequate traspirability on the 
wound site when gelled, fluid permeability of the different formulations was 
also evaluated as water vapour trasmission rate (WVTR) after swelling 
process in order to ensure that gel layers would provide adequate level of 
moisture at wound bed. WVTR was evaluated by incubating swollen hydrogel 
in a moisture rich environment (108) at 37°C.  In situ formed hydrogel of all 
formulations exhibited WVTR values ranging between 95 g/m2/h (GAPNs9) 
and 90 g/m2/h (GAPNs1), depending on particle diameter. Hydrogels 
generated by smaller particles were probably tighter compared to those 
obtained from particles with larger diameters resulting in a slower water 
release. However, these values are all in the recommended range (80-105 
g/m2/h) to avoid exudate build up as well as excessive wound dehydration 
then, hydrogel might be able to maintain a proper fluid equilibrium at wound 
bed (109, 110). 
After the complete gel formation, was important to study the fluid loss in order 
to understand if after use the gel was easily removable. Infact, a massive water 
loss produces a dried alginate layer, that can cause trauma when removed.  
Fluid loss was faster in the first 12 h with formulations loosing around 50% of 
the fluid whereas, after 2 days, hydrogels still retained over 30% of fluid. 
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Subsequently there was a tiny water loss from the gel until equilibrium was 
reached with formulations retaining between 10 and 15% of water after 5 days 
depending on feed concentration and mesh nozzle diameter; the lower feed 
concentration and nozzle diameter the lower the retained water. These values 
show that the quantity of water retained is still good for an easy removal. 
 
Figure 29: Water loss profile of gel formulations, measured as weight loss during time. 
Red line: GAPNs1 (0.1%, 4 µm), Blue line: GAPNs9 (0.5%7 µm). 
Stability tests were conducted in accelerated conditions (40°C, 75% moisture 
level) following ICH Q1AR2 guide in order to verify the stability of 
gentamicin entrapped into the polymeric matrix over time. Results showed that 
GS content was preserved till 6 months in harsh conditions. In fact, even if 
raw GS is a deliquescent material when non-encapsulated, only slight increase 
in water content was detected after 6 months, for all manufactured 
formulations. It can be suggested that polymeric materials acting as barrier 
against moisture penetration strongly reduced GS water uptake in accelerated 
stored conditions. 
GS release behaviour from in situ formed gel was monitored using vertical 
Franz-type diffusion cells with SWF (simulated wound fluid) in the acceptor 
compartment. Figure 30 showes GS permeation curves of GAPNs micro and 
nanoparticles in comparison to GS as raw material. Gentamicin permeation 
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profiles from particles made by nanospray drier were related particle size and 
feed solution concentration, both affecting hydrogel consistence. In fact, 
microparticles, produced with 7 mm nozzle mesh exhibited a faster permeation 
rate, achieving total release of the drug between 2 and 3 days according to the 
increasing in feed concentration while, 4 µm nozzle mesh nanoparticles, 
released drug between 4 and 6 days (in SWF). All formulations exhibited a 
drug burst effect within 4 h from administration that can result very useful to 
prevent infection spreading at the beginning of a local antibiotic therapy. As 
expected, burst effect was related to sol-gel process kinetic and gel texture 
(111). In fact, slower gel formation for microparticles (GAPNs7–9) resulted in 
the release of 40–50% of the loaded gentamicin whereas nano-particulate 
powders, GAPNs1–3, released 20–35% of the loaded GS by burst effect. 
Prolonged release of GS from GAPNs' formulations was achieved by in situ 
gel formation that acted as a barrier to drug release slowing down permeation 
rate (following a non-fickian diffusion kinetic) in contrast with fast permeation 
of GS raw material. 
 
Figure 30: Drug relese profile of GAPNs9 (green), GAPNs7 (orange), GAPNs3 (blue), 
GAPNs1(carmine), compared to GS raw material (red). 
Another important characteristic of the gel is its adhesiveness. The formed gel, 
infact, should properly adhere into the wound bed with an easy removal after 
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use, but avoiding, at the same time, gel loss or accidental detachment during 
the use. The adhesive strength of in situ formed hydrogel was evaluated using 
a modified protocol of ASTM D3808 standard. Nitrocellulose membrane filter 
(0.45 mm pore size) conditioned with SWF was used as adhesion substrate. 
Adhesive strength for the formulations was in the range 5.7–9.5 kPa with 
maximum adhesiveness exhibited by gel formed by nanoparticulate powders 
of GAPNs series produced with 4µm nozzle due to the formation of highly 
entangled gel texture during the powder swelling (112-114). The smaller the 
particles, the more entangled the gel texture and consequently the higher the 
adhesiveness. The values showed in the graph of figure 31 were in the proper 
range to foresee an ideal behaviour in the wound site. 
 
 
Figure 31: Adhesive strengt graph for the different formulations.  
With the aim to evaluate the formulations antimicrobial effect over time, disc 
diffusion and time-killing assays were conducted against both S. aureus and P. 
aeruginosa. A modified disc diffusion test conducted on a Muller-Hinton agar 
plate spreaded with S. aereus demonstrated that the inhibition zone produced 
by any GAPNs formulation was larger than pure GS at both 24 h and 6 days. 
The inhibition zone of bacterial growth was larger around the in situ formed 
gel produced by GAPNs1–3 formulations (13.6 mm) compared to the 
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homologous formulations GAPNs7–9 (12.8 mm) whereas pure GS produced 
an inhibition zone of 11.3 mm (figure 29). 
 
            
Figure 32: On the left two formulations compared to GS raw material in the disc 
diffusion test for P. aeruginosa and S. aureus. On the right time killing assay on S. 
aureus to compare the antimicrobial effect of GAPNs1 (dark red), of GAPNs9 (green) 
and of GS raw material (red). 
Results of a representative time-killing assay against S. aureus, measuring the 
reduction of CFU (colony forming unit) recovered at day 3, 6, 9 and 12, are 
reported in Figure 32. All formulations showed high bactericidal activity 
against S. aureus, comparable to GS till 6 days. Reduction of CFU till 12 days 
demonstrated that GAPNs formulation exert a prolonged bactericidal activity, 
whereas pure GS loosed its activity after 6 days. Formulations killing activity, 
in accordance with permeation profiles, was related to particle size and gel 
formation rate. In fact, GAPNs1 (smallest nanoparticles, higher gelling rate) 
showed a bactericidal activity about 3 fold higher than GAPNs9 till day 9 and 
it resulted almost doubled at day 12. 
 
In conclusion, nano spray drying technology has been successfully applied to 
produce stable alginate/pectin based nanoparticulate powders with good 
gentamicin content. Powders would be able to gelify rapidly into wound bed 
cavity, absorbing large quantities of wound fluid, due to dextran blend 
swelling properties. Moreover, in situ formed gels exhibit proper adhesiveness 
78 
 
to allow easy removal from wound bed and WVTR enabling a proper 
equilibrium of the wound fluids. Release of encapsulated GS from 
nanocarriers exhibits a burst effect suitable to prevent infection spreading at 
the beginning of a local antibiotic therapy. Sustained release, following the 
initial burst of drug, prolonged GS permeation depending on particles size and 






3.1.2 Doxycycline, alginate, chitosan and pectin Nano spray drying 
formulations 
Nanospray with optimized condition was tested for the production of more 
complex dry powders, constituted by polymers with proper characteristics for 
wound healing, comparing results with conventional Mini spray drying. 
This research study was, infact, focused on the production of an innovative in 
situ gelling dry powder based on different polymers used as adiuvant in the 
wound healing process and as carrier for doxycycline. The different molecular 
mechanisms of the polymers alginate and chitosan were considered in order to 
enhance both wound healing and drug efficacy. In fact, properties of alginate 
containing high M residues are well known (61), while chitosan low molecular 
weight enhances the functions of inflammatory cells by a binding on mannose 
receptors, which mediate the internalization of chitosan particles (58). Pectin 
high amidation degree was also added to speed up the powder gelification 
(115), improving the overall formulation performance. The different polymers 
were individually studied in this application, their behaviour in powder 
formulation was well known, but it was intersing to study their synergy on 
wounds. Doxycycline was used as antimicrobial drug model. It is a wide range 
spectrum tetracycline with high potency, active on both gram negative and 
gram positive bacteria, also able to inhibit MMP9 with positive effects on 
wound healing(116, 117).  
 
Figure 33: Doxycycline 
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Dry powders were produced using nano spray drier and mini spray drier used 
as comparison, both with optimized conditions. 
Preliminary studies were conducted to evaluate the proper conditions for feed 
preparation. In fact, alginate and pectin are soluble in distilled water, whereas 
chitosan is soluble in aqueous acidic solution where alginate can precipitate. 
Good results in feeds processability were obtained when chitosan was set as 
1:6 compared to other polymers and final solution pH was set at 5.5. 
Therefore, different formulations were obtained by setting alginate/chitosan 
ratio at 6:1 (ACD formulations) and doxycycline at 1.43%w/w of the 
polymers; alginate/pectin/chitosan/doxycycline in the ratio 3:3:1:0.1 (APCD 
formualations); alginate/pectin ratio 1:1 and doxycycline 1.43% of polymers 
(APD formulations). Moreover, in order to understand the influence of 
encapsulation technology on powder technological properties feeds were 
processed by both mini- and nano-spray drying. 
Table 2: Yield, drug content, encapsulation efficiency and drug content after 














ACDN Nano spray A:C:D 6:1:0.1 97.65 1.06±0.01 74.58±0.13 1.94 ±0,01 2.44±0.02 
APCDN Nano spray A:P:C:D 3:3:1:0.1 99.22 0.84±0.01 61.01±0.01 1.74±0,01 1.89±0.02 
APDN Nano spray A:P:D 3:3:0.1 69.23 1.24±0.00 86.13±0.01 1.62±0,02 2.22±0.01 
ACDM Mini spray A:C:D 6:1:0.1 45 1.09±0.01 76.60±0.01 1.79±0,02 3.33±0.03 
APCDM Mini spray A:P:C:D 3:3:1:0.1 40 1.21±0,00 84.44±0.14 1.85±0,03 2.38±0.01 
APDM Mini spray A:P:D 3:3:0.1 31 1.43±0,01 98.22±0.01 1.64±0,02 2.70±0.02 
As shown in table 2, the yield obtained by nanospray drying process was 
always higher than mini spray drying, due to the differences in process 
characteristics. This result confirms what observed in the previous work on 
Gentamicin loaded formulations in which was studied that the electrostatic 
collector is able to enhance process yield by strongly reducing particle waste 
on glass walls. 
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Drug content (d.c.) and encapsulation efficiency (e.e.) studies were conducted 
using Uv-vis spectroscopy, extracting drug from the polymeric matrix with a 
specific and validated protocol (paragraph 2.4.2). All formulation showed 
good encapsulation efficiency, particularly when alginate/pectin blend was 
used as carrier. Formulations were also tested for stability in accelerated 
conditions (40°C, 75% moisture). After one month, drug content was almost 
superimposable to fresh powders, with only a slight decrease (between 4 and 
5%), showing that polymers are able to protect doxycycline from degradation 
(118). 
Particle morphology was studied by scanning electron microscopy (SEM), 
comparing the different formulations and the two different encapsulation 
techniques.  
 
Figure 34: First line on the top: ACDM, APCDM and APDM produced by minispray 
drying. Second line ACDN, APCDN and APDN produced by nanospray drying. 
All mini spray dried formulations presented spherical shape, with the presence 
of some craters; APCDM and APDM presented rougher surface due to the 
presence of chitosan. Nano spray dried particles were very similar to mini 
spray dried ones but smaller in size. Formulations APD (figure 34 f) presented 
smooth surface and the smallest size. 
In order to study powders flowability, an important characteristic for powder 
easy administration, Hausner ratio was evaluated. As comparison, a similar 
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formulation present on the market (Cicatrene ®) was tested and, the Hausner 
value of 1.85, was considered ideal. Table two shows the results of Hausner 
ratio and density (obtained by helium pycnometer).  
Nano spray dried powders showed higher flowability compared to mini spray 
dried formulations. Moreover, APCDs presented the lowest Hausner index 
(APCDN) whereas ACDs exhibited the highest values. Flowability is 
generally correlated to particle size but the SEM extensive analyses showed 
that particle roughness was able to strongly affect powder floability, in spite of 
the particle size, due to the increasing effective contact surface area. 
Density values were slightly different between formulations produced with the 
two techniques. Density is related to matrix consistency which is related to the 
encapsulation technique. Infact, the different atomization mechanisms lead to 
the formation of a different flow of droplets into the drying chamber (119). 
This is more evident in formulations made with chitosan, where density values 
are different between mini- and nano spray dried particles. 
An in situ gelling formulation should become rapidly a gel when in contact 
with wound exhudates and should be able to cover the wound bed 
homogeneously. To study this kind of behaviour, all formulations were placed 
in contact with simulated wound fluid and at defined time point the increase in 
weight was calculated. 
Figure 35 shows shows gel formation. The formulation APCD had the faster 
fluid uptake ability, becoming gel in 5 minutes for nanospray powders 
(APCDN) and in about 10 minutes for mini spray formulations (APCDM). 
This result was quite different from that obtained in the previous work in 
which a low methoxyl degree pectin was used. In fact, the use of pectin with 
high amidation degree speed-up powders ability to gel, reducing total gelling 
time from 15 to 5 minutes (95) . 
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Figure 35: On the left APCDN in dry state. On the right the gelled powder after 5 
minutes. 
The increase in weight was about 15 times for mini spray powders and above 
16 times for nano spray formulations, due to the wider exposed surface area of 
particles (figures 36 and 37). 
 

































Figure 37: Nano spray drying formulations swelling rate (APDN green, APCDN red, 
ACDN blue). 
In figure 38 and 39 are reported the calorimetric thermograms of polymers as 
raw material compared to blank formulations (figure 38), and the thermograms 
of doxycycline loaded formulations compared to pure doxycycline (figure 39).  
Alginate showed an exothermic peak at 250 °C whereas chitosan at 300 °C 
due to polymer degradation. Amidated pectin showed a crystalline 
endothermic peak at 150°C, a broad peak at 190 °C followed by an exothermic 
one at 250°C. 
Blank formulations showed different thermal profiles. ACs blank 
formulations, both mini- and nano spray dried, exhibited a new peak at 150°C, 
not observed in raw materials, probably due to alginate-chitosan ionic 
interaction and an exothermic related to polymers degradation similar to 
alginate. APs formulation showed a thermal behaviuor presenting polymers 
degradation peak at 240 °C, and the melting peak shifted at lower temperature, 
145°C, due to the formation of a homogeneous polymer matrix into particles. 
APCs blank showed a melting peak shifted at higher value than ACs (170°C), 
due to the interaction of the three polymers, as well as, it was possible to 































Figure 38: DSC thermograms of pectin (violet), alginate (yellow) and chitosan (green) 
raw material in comparison with APM (blue), APCM (red) and ACM (black) blank 
formulations. 
 
Figure 39: DSC thermograms of ACD (black), APCD (red), APD (blue) doxycycline 
loaded formulation in comparison with doxycycline raw material (violet). 
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In figure 39 graphs were compared with doxycycline, which thermogram 
exhibited the profile of a crystalline material with and endothermic melting 
peak at 168°C followed by an exothermic peak at 225°C due to drug 
degradation.  
Doxycycline loaded formulations exhibited similar behaviour to the blank 
homologous but both melting and degradation peaks were shifted at higher 
temperature. This phenomenon can be explained by the interaction between 
doxycycline and polymer matrix. Such interaction could be responsible of a 
prolonged drug release from the formulations. The slight differences in the 
peaks are probably related to the low ratio between polymers and drug into the 
formulations 
In order to study the drug release, in vitro permeation experiments were 
performed using franz type diffusion cells, using SWF as acceptor fluid. 
Results were compared to doxycycline raw material that permeates in a few 
minutes (about 20). APDN, APCDN and ACDN showed a burst effect in the 
first hours (3 h) with 50 to 70% of drug released and a prolonged release till 
48 h. APDN and ACDN showed almost the same behaviour with 60% released 
in 4 hours.  
APDM, APCDM and ACDM showed a similar behavior, with a lower burst 
effect (4 h) with a quantity released of 45-50%, reaching the total release of 
the drug in 50 h.  
An initial burst effect within 3 or 4 h from administration that can result very 
useful to prevent infection spreading at the beginning of a local antibiotic 
therapy. 
The prolonged release showed by formulations, confirmed that drug/polymer 




Nano spray formulations showed a faster release than mini spray homologous, 
related to the sol-gel convertion. The smaller the particles (with a lower mean 
diameter), the higher the burst effect. 
 
Figure 40: drug release profiles of nano spray dried formulations in comparison with 
pure doxycycline. ACDN (blue), APCDN (red) and APDN (green). 
 
Figure 41 drug release profiles of mini spray dried formulations in comparison with 
pure doxycycline. ACDM (blue), APCDM (red) and APDM (green). 
Antimicrobial in vitro studies on S. aureus performed using a time killing test, 
showed that all formulation had a better antimicrobial activity than pure 
doxycycline and control. At the seventh day, ACDM, APDM and APDN 
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showed the longer activity, whereas other fomultions had a comparable 
activity to pure doxycycline. As shown in the figure 42, there is a good 
correlation between the antimicrobial activity and the permeation profiles. The 
slower the release, the longer the activity. In fact, APDM and APDN were still 
active at the seventh day, whereas other formulations presented lower activity 
at the same time. 
 
Figure 42: Time killing test on S. aureus for all formulations.  
 
In conclusion, in this study highlighted the possibility to use Nano spray 
drying with optimized conditions successfully, also for the production of more 
complex dry powders.  
The doxycycline based formulations, showed to be able to effectively contrast 
bacterial growth, in the in vitro tests performed. Using proper excipients, such 
as alginate, chitosan and amidated pectin it is possible to control drug release 
till 48 hours, and to have rapid gelation of dry powders when in contact with 
wound exudates.  
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Nevertheless, powders have good flowability properties, so they could be 
easily administrated at the wound site. 
Further studies are needed to assess doxycycline inhibiting activity on MMP9 









































3.2 SECTION B 




























































































3.2.1.1 SAA vs Mini spray drying 
SAA is one of the most promising supercritical fluid based technique for 
application in the field of pharmaceutical products because of the well known 
advantages of supercritical CO2 and the high yields gettable. 
The contact between feed solution/dispersion and SC-CO2 determines the 
formation of an expanded liquid of reduced viscosity and surface tension, with 
a consequent improved atomization and the formation of particles with 
specific characteristics. 
During this study, SAA was applied for the production of in situ gelling 
powders loaded with Gentamicin for topical treatment of infected wounds, in 
which microorganisms have interfered with normal healing process. 
Antibacterial agents, infact, should be topically administered in order to 
reduce wound bioburden and to avoid infection spreading, as well as systemic 
side effects. A number of wound dressing devices loaded with active 
pharmaceutical ingredients (APIs) have been manufactured with different 
polymeric materials. The ideal dressing material should have proper adherence 
to the wound site and good exudate absorbance. It should be able to maintain 
appropriate moisture at the wound bed, nonetheless, easy application and 
removal.  
Dextran hydrogels may combine most of these properties; moreover, they are 
transparent allowing the monitoring of healing process. In this work, alginate 
and pectin were chosen as biocompatible and biodegradable carrier for drugs. 
Alginate is extracted from brown algae, and it’s a linear co-polymer composed 
by monomeric units of guluronic acid (G) and mannuronic acid (M). High G 
content alginates have been demonstrated to be less liquid absorbent and gel 
forming than high M content alginates, nevertheless they retain a stronger 
structure and are able to gel in the presence of Na+ ions highly concentrated in 
wound fluids (120). Otherwise, M residues has a well known activity as 
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discussed previously (61), as well as pectin low methoxyl degree, from citrus 
fruit, a natural polysaccaride consisting in D-galatturonic acid units linked by 
an α-(1-4) bond, was used to speed up the fluid uptake when in contact with 
wound exudates.  
The conformability problems of conventional alginate dressing, as well as 
other dextran dressing, produced in form of sheets or membranes (121-123) 
are overcome by in situ forming hydrogels that could fit the irregular shape of 
the wound avoiding wrinkles or fluting (109, 123). Also other kinds of 
formulation available on the market, as spray-on films, have shown partially 
reduced conformability and high costs, complex manufacturing and, in some 
cases, bacterial spreading when used over third degree wounds (124-126). 
Then a formulation in form of dry powder can overcome these problems, 
because is able to cover the whole wound bed, avoiding removal trauma, and 
permitting the drug release control. 
a  
b  
Figure 43: a) Sodium alginate. b) Pectin 
The active drug chosen was gentamicin sulfate (GS) that is an aminoglycoside 
antibiotic worldwide used for the treatment of severe infections caused by both 
Gram-positive and, especially, Gram-negative bacteria (127). Considering the 
systemic administration, multiple daily doses are required to achieve a good 
local antibiotic concentrations due to its pharmacokinetics and 
biopharmaceutical properties; consequently many side effects such as 
nefrotoxycity and otoxycity are observed (128, 129). In the last few years, 
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different GS loaded polymer delivery systems intended for local 
administration, obtained by different techniques, have been designed to 
overcome drug systemic disadvantages by maintaining high local antibiotic 
concentration, to reduce side effects and induced bacterial resistance (130-
132). 
 
Figure 44: Gentamicin Sulphate. 
The alginate-pectin blend loaded with gentamicin of this work was produced 
in form of dry powder comparing two different technologies: Spray-drying 
(SD) and Supercritical Assisted Atomization (SAA) based on supercritical 
carbon dioxide. 
Optimized parameters were used for both SD (Mini spray drying Buchi B191): 
and SAA (paragraph 2.4.1.1). 
 Both the techniques trasform a liquid solution/suspension in a dry powder 
with proper characteristic studied in this work. Feed solution of Gentamicin-
Alginate-Pectine were produced with 1:1:1 e 1:3:1 ratio and with total 
component concentration of 0.5 and 1%. Samples GAPS are produced by 
spray drying (SD) whereas GAP are the SAA particles. GAPS and GAP 1-2 
are produced with drug/polymer ratio of 1:1:1 whereas GAPS and GAP 3-4 
with a 1:3:1 ratio. 
Both the process lead to high yields, from 42 to 68% for SD and from 66 to 
74% for SAA. 
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Table 3: Yield, Particle size and span, drug content., encapsulation efficiency and 






















GAPS1 1:1:1 0.5% 68.4±2.3 3.88 (1.19) 28.6±0.5 7.6±0.2 85.7±0.3 
GAPS2 1:1:1 1.0% 57.6±2.8 4.10 (1.27) 30.3±0.4 7.9±0.3 90.9±0.4 
GAPS3 1:3:1 0.5% 42.7±2.1 3.70 (1.29) 17.2±0.3 8.7±0.4 86.1±0.4 
GAPS4 1:3:1 1.0% 49.9±2.9 4.07 (1.43) 16.8±0.2 9.1±0.4 84.2±0.5 
               
GAP1 1:1:1 0.5% 74.2±1.2 1.91 (1.07) 35.1±0.4 5.1±0.2 > 100 
GAP2 1:1:1 1.0% 68.7±1.1 1.82 (1.19) 39.4±0.6 4.7±0.3 > 100 
GAP3 1:3:1 0.5% 70.6±1.2 1.45 (1.15) 21.2±0.2 5.0±0.3 > 100 
GAP4 1:3:1 1.0% 66.1±1.1 1.39 (1.13) 29.6±0.1 4.4±0.2 > 100 
 Scanning electron microscopy (SEM) and laser scattering (LS) allowed to 
study morphology and dimension of the sample produced. Shape and particle 
size distribution were influenced by the technology. SAA particles were 
spherical with narrower size distribution and smaller diameter looking at d50 
that ranged between 1.39 and 1.91 μm, whereas SD were corrugated with d50 
ranging between 3.92 and 4.10 μm. It was also noticed that d50 increases with 
GS content and with decrease of polymer concentration. 
The particle shape and dimension are also shown in the SEM images in the 
figure below. SAA particles (figure 45 a-d) are more spherical and uniform 
than SD. This depends on the different mechanism of particle formation and 
solvent elimination. 
 
Figure 45: SEM images of GAP (upper line) and GAPS (lower line) 
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 SAA apparatus allows the formation of primary droplets by the spray trough 
the nozzle. These droplets contain also supercritical CO2 that into the 
precipitation chamber at atmospheric pressure becomes gas allowing the 
fragmentation of primary droplets into secondary ones. These conditions allow 
to obtain a more uniform particle formation and solvent elimination, than SD.  
Drug content (d.c.) and encapsulation efficiency (e.e.) were evaluated by 
HPLC analysis using a modified pharmacopoeia method (99).  
Both techniques produced powders with high e.e.: spray-drying e.e. ranged 
between 84.2 and 90.9% depending on the feed while encapsulation efficiency 
obtained by SAA was always slightly higher than 100%. This phenomenon, as 
previously described (99), is related to the precipitation of small quantities of 
polymer material into the precipitation chamber due to the so called anti-
solvent effect. Thus, the final calculation of drug content is related to a lower 
total polymer mass, giving an efficiency >100%. 
Water content, measured by means of Karl Fisher tritation of spray dried 
microparticles was higher than SAA’s. This can suggest that during 
decompressive atomization a reduction in surface tension of the feed takes 
place, due to supercritical CO2 mixing with feed, allowing faster and more 
efficient elimination of water from polymer matrix during particle formation 
(75, 133). 
Good powder flowability, high fluid absorbing capacity as well as water 
permeability at the equilibrium are among the most important properties 
required for wound dressing preparation to maintain the optimal environment 
at the wound bed and to enhance healing process (106). The tapped density 
(ρT) e bulk density (ρB) ratio was evaluated as Hausner index (HI). These 
values were also compared to that of a commercial formulation which was 
established at 1.85. HI for SD particles was between 2.00 - 2.44, whereas SAA 
powders showed values closer to the commercial formulation, ranging 
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between 1.97 -2.51, that indicate the good flowability of powders and their 
easily administration. 
As well known, Hausner ratio (ρT/ρB) is strictly correlated to particles size but 
it is also influenced by their shape and roughness. Consequently, both 
sphericity coefficient (SC) and surface roughness (SR) for GAP and GAPS 
microparticles were evaluated. 
Because of powders should gel in situ, absorbing the wound exudates, samples 
fluid uptake ability was evaluated in vitro using a specific protocol (paragraph 
2.4.2). The increasing in weight of the dry powder and the speed of gel 
formation was evaluated. GAPS formulation showed a gel/powder ratio 
ranging between 11.91 and 14.81 whereas GAP ratio was included between 
12.27 and 14.19. Complete gelification happened in 30 minutes for GAPS and 
in 25 minutes for GAP. As expected, fluid uptake was directly related to 
alginate content. Furthermore, SAA particles show a faster gelification speed 
due to their higher surface area at the same weight compared to SD particles. 
                          
Figure 46: Gelification of a GAP powder in 15 minutes when in contact with simulated 
wound fluid. 
A topical formulation for wound healing should provide an adequate 
traspirability. Then fluid permeability of the different formulations was also 
evaluated as water loss after swelling process in order to ensure that gel layers 
would provide adequate level of moisture at wound bed. The values of this 
parameter, named water vapour trasmission rate (WVTR), reported in 
literature, should range between 80 and 105 g/m2h to avoid wound occlusion 
or loss of liquids with consequent dehydration. 
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All GAP formulations presented WVTR values between 93 and 98, then, in 
the appropriate range to maintain a proper fluid equilibrium. GAPS3-4 showed 
suitable WVTR (103 and 102) whereas GAPS1-2 WVTR was higher (111 and 
110, respectively), but still acceptable. The results from these preliminary 
studies show that gel obtained by any GAP or GAPS formulation can produce 
the proper environmental characteristics to promote wound healing. 
Storage stability test, conducted in accelerated conditions (40°C, 75% 
moisture degree) following ICH Q1AR2 guide, highlighted that GS content is 
stable even in harsh condotions and also the water content doesn’t increase 
significantly in three months (about 5%) as well as thermal behavior doesn’t 
change significantly. 
An important goal of this formulation was the optimization of drug release 
kinetics from swellable and erodible polymers, as a function of the wound 
treat (i.e. ulcers, pressure sores). Hence, permeation profiles of the 
encapsulated antibiotic were obtained in vitro by means of franz type diffusion 
cell, in order to study the GAP and GAPS in vitro behaviour (2.4.2). Results 
were compared to that of pure GS which permeates in three hours, as expected 
for a completely water soluble drug of class I BCS.  
Regarding GAPS and GAP formulation, their behviour was influenced by 
drug/polymer ratio and manufacturing process. 
Micro-particles produced by spray drying GAPS exhibited the faster 
permeation rate, achieving total release of the drug into the acceptor 
compartment between 4 and 6 days according to the increasing in polymer 
blend concentration, whereas GAP (formulations released the total amount of 
the encapsulated GS) between 8 to 10 days (in SWF). Moreover, both GAPS 
and GAP microparticles exhibited a drug burst effect within 7 h related to 
particles hydration kinetic, resulting in the release of almost 50% of the loaded 
drug in 6 h for GAP1 and GAPS1 (formulations) while GAPS4, that showed 
the slowest hydration rate, released in 6 h 35% of the loaded GS. 
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 Such intensive release of gentamicin in the first 6 h of administration, 
followed by a prolonged release, could be very useful to prevent infection 
spreading at the beginning of a local antibiotic therapy maintaining high local 
antibiotic concentration for an extended period of time. 
 
  
Figure 47: Drug release profile of GAP1, GAPS1 (blue and green) and GAP4, GAPS4 
(orange and violet) compared to GS raw material (red line). 
Preliminar microbiological assays allowed to evaluate the antimicrobial 
activity of the formulation aganist S. aureus and P. aeruginosa that are the 
most frequently bacteria found in wounds. The time killing test conducted on 
S. aureus measured the reduction of the number of CFU (colony forming unit) 
recovered at 6, 12 and 24 days. Differently from GS that loses its activity in 6 
days, formulations showed activity till 24 days. Moreover, during the first 6 
days, all formulations, with the exception of GAP4, showed a bactericidal 
activity against S. aureus comparable to GS. GAP powders had an activity 
from 12 to 4 folds greater than GS, whereas GAPS had from 6 to 2 folds 
greater bactericidal activity if compared to pure antibiotic at 12 days. 




Figure 48: Time killing test on S. aureus. Red: day 6, yellow: day 12 and blu: day 24. 
Regarding P. aeruginosa it’s well known its ability of attachment surfaces 
and subsequent biofilm formation that are important steps in the establishment 
of chronic infections and persistence in host tissues. GAP and GAPS 
formulation were tested in order to evaluate their ability on degradation of 
preformed biofilm. GS destroyed only 10% of biofilm whereas formulations 
degraded till 90%; furthermore, this ability was strictly correlated to 
drug/polymer ratio. In fact, formulations with higher drug content, GAP1-2 
and GAPS1-2, were able to degrade 90–80%, respectively, whereas GAP3-4 
and GAPS3-4 with the lower drug/polymer ratio were able to degrade 50–40% 
of the preformed biofilm (figure 49).  
A disc diffusion test conducted in Petri plates with muller hinton agar 
spreaded with both S. aureus and P. aeruginosa showed that the inhibition 
zone of bacterial growth was larger around thein situ formed gel produced by 
GAP compared to GAPS homologousformulations. In particular, an inhibition 
zone diameter ranging from 12.5 to 10.5 mm and from 10.5 and 7.0 mm was 




Figure 49: Degradation test on pre-formed biofilm of P. aeruginosa. 
In conclusion, SAA technique as well as spray drying were able to obtain in 
situ gelling dry powders with high GS content. Powders are able to gel quickly 
when in contact with wound simulated exudates, and to maintain the proper 
wound environment suitable for healing as demonstrated by the WVTR 
values. Release of encapsulated GS from microparticulate systems follows a 
non-fickian diffusion kinetics with burst effect suitable to prevent infection 
spreading at the beginning of a local antibiotic therapy and enabling to prolong 
drug release till 10 days depending on drug/polymers ratio and manufacturing 
technology.  
Furthermore, GAP and GAPS formulations showed a stronger antimicrobial 
activity than pure GS on both S. aureus and P. aeruginosa, allowing a good 





















































3.2.2.1 Aerogel preparation by optimization of process parameters  
Aerogels are a class of nanoporous materials characterized by open pore 
structure and high surface area, and considered promising carriers for drug 
delivery. Dextran-based aerogels are very attractive because of their 
availability, biocompatibility, biodegradability, and low cost process as well as 
to their ability to entrap drugs and modulate the release kinetics. Alginate 
matrix has also been used to deliver drugs or peptides as encapsulated 
components, protecting the therapeutic agent by environmental 
stress/degradation (134, 135). 
Consequently, they can act as delivery systems generally enhancing the 
bioavailability of the loaded drug (136).  
Furthermore, their nanoporous structure can absorb large quantities of liquids, 
such as exudates, making them very interesting in wound healing applications. 
In this work alginate hydrogel processed by prilling were produced and dried 
by Supercritical Antisolvent Extraction in order to test the feasibility of the 
tandem technique prilling/SAE, tuned in this work for the first time, and to 
optimize the process parameters of both techniques.  
Prilling or laminar jet break-up is a mild encapsulation technique useful to 
obtain polymeric particles with narrow size distribution. Alginate polymeric 
solution at concentration of 2% w/w were produced by adding a proper 
polymeric powder amount into distilled water under gentle stirring. The 
solution formed was processed by prilling at 300 Hz of frequence, 10 ml/min 
feed rate and with a 600 µm nozzle.  
The droplet formed by the laminar jet break-up falled into a CaCl2 0.5M 
gelling solution and left into this bath for 5 minutes. The hydrogels formed 
were then put in a proper organic solvent (ethanol and acetone) for 5 h to 
obtain a complete and efficient water elimination and then supercritical 
process was performed. The water in hydrogel, in fact, cannot be direct 
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removed by SC−CO2 drying because this fluid shows only a very limited 
affinity with water; therefore, a solvent exchange step is required. 
 In this study, different exchange solvents and drying conditions were tested to 
preserve the original gel internal nanostructure of alginate aerogels. 
Morphological analysis by means of scanning electron microscopy and 
calculation of shrinking factors were used to evaluate the differences between 
the different solvent exchange. 
Shrinking factor is calculated by the following equation: 
𝑆ℎ𝑟𝑖𝑛𝑘𝑖𝑛𝑔 % = 𝑑ℎ −
𝑑𝑑
𝑑ℎ
∗ 100    (6) 
where dh is the diameter of hydrated particle and dd the diameter of the dried 
one. 
Particularly ethanol and acetone were selected for this work. The operating 
pressure and temperature ranges were chosen by considering the vapor−liquid 
equilibra (VLE) of the two supercritical mixtures selected, namely, 
ethanol/CO2 and acetone/CO2, to work above their mixture critical point 
(MCP) (137). Indeed, the works on alginate hydrogel drying were performed 
at pressure and temperature conditions near the pure CO2 critical point.  
Regarding the mixture ethanol/CO2 using an extraction time of 90 min, 
hydrogel beads were dried at different operating temperatures of 32, 35, and 
38 °C and at different pressures of 100 and 150 bar. It should be noted that 
CO2 density is directly connected to its solvent power and increases with 
pressure, whereas it decreases with increasing temperature. At 100 bar the 
binary mixture ethanol/CO2 formed into the beads was too close to its MCP 
causing a non-uniform extraction. When the SC drying was performed at 150 
bar, all alginate beads were spherical and clearly white. A summary of the 
results obtained at 150 bar and 38 °C, in terms of shrinking factors (SFs), is 
reported in Table 4.  
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The lowest SF value (0.6%) was, infact, measured operating at 150 bar and 38 
°C which corresponds to a CO2 density of 794 g/cm3. At CO2 densities higher 
than 800 kg/m3 (operating at 150 bar and at 32 and 35 °C), larger bead 
shrinkages of 4% and 6% were observed. 
Also the lowest solvent residues were found with these conditions, that were 
considered the optimal. 
SC drying for the mixture acetone/CO2 was performed at the same operating 
temperatures and pressures as for ethanol. At both operating pressures, the 
beads produced were spherical and clearly white with a uniform and 
homogeneous internal nanostructure. Additionally, the SF value was always 
very low and ranged between 0.6% and 2% with respect to the original bead 
diameter when operating at 150 bar and between 0.3% and 0.9% when 
operating at 100 bar. The best results in terms of SF and solvent residue were 
found at 100 bar and 38°C (table 4). 
Table 4: Optimized SAE parameters for both acetone and ethanol as co-solvents. 
Shrinkage factor and solvent residue in these conditions are reported. 
 
Because the MCPs of the ethanol/CO2 and acetone/CO2 systems at the selected 
temperatures are located at very similar pressures (Figure 50), the different 
processing results do not seem to depend on the distance of the operative 
points from the corresponding MCP but rather on the different affinities of the 
two organic solvents with SC-CO2. This evidence can also be deduced from 
VLE diagrams (figure 50), in which the area of the two-phase region (at the 
same temperature) is very different for the two systems. Ehanol/CO2 exhibits a 
larger biphasic region than acetone/CO2, showing that acetone and CO2 have 
larger compatibility. Another possible explanation is related to the 
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composition of the solvent CO2 in the beads and can be described with a 
composition path starting from pure solvent to practically pure CO2 at the end 
of the drying process, as indicated by the red line in figure 50. 
              
Figure 50: On the left: VLE for the mixture Ethanol/CO2, on the right VLE 
Acetone/CO2. 
When the drying process has been performed at lower pressure (100 bar), it is 
possible that in the case of ethanol/CO2 the system has maintained a higher 
surface tension when the expanded liquid region has been crossed (the region 
of the diagram on the left of the MCP). This event can produce the observed 
lower efficiency in the case of ethanol drying for the drying process at lower 
pressure. 
However, because of ethanol is a better solvent for pharmaceutical products 
than acetone, due to its safety, it was preferred to acetone for the following 
applications. 
Aerogel produced by the supercritical extraction of solvents using supercritical 
carbon dioxide based processes, can be applied in pharmaceuticals due to the 
mild and green conditions of the process as well as low cost, and to overcome 
the traditional process limitations.  
The process allows a fast and effective solvent elimination, preserving the 
original gel nanostructure (67, 138) because of the near zero surface tension of 
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the CO2 solvent mixture that prevents the structure collapsing during drying. 
The process is also very fast and yields a complete solvent elimination (71, 
139). Indeed, supercritical carbon dioxide (SC-CO2) shows a large affinity 
with almost all the organic solvents, and because of its gas-like diffusivity, it 
has been proposed for the production of several innovative materials such as 
porous membranes (66, 140), biopolymer microspheres (141, 142), or micro- 
and nano-particles (143, 144). 
Using the optimized conditions studied in this work, nanostructured and 
completely dry particles were obtained, homogeneous in shape and dimension. 
              
Figure 51: Internal structure of half beads criofractured with liquid N2. a) alginate 
beads extracted with ethanol, b) alginate beads extracted with acetone, c) alginate 
beads dryied using convective methods. 
SEM images show a half particle of aerogel obtained after ethanol solvent 
exchange (51 a) and an aerogel obtained after acetone solvent exchange and of 
an alginate beads dried by conventional techniques (51 b). As shown in the 
figure, the nanoporous network of about 200 nm was maintained after the 
supercritical drying for both the solvent used for the exchange step, whereas a 
completely collapsed matrix derives from traditional convective drying 
methods. These characteristic of the matrix are directly correlated to the ability 
of alginate particles to control the drug release and to obtain a proper release 
kinetic. 
  












3.2.2.2 Co-axial prilling/SAE 
The optimization of process parameters of prilling/SAE tandem technique, 
performed in the previous study, was useful for its application in an innovative 
configuration. 
Prilling, a mild encapsualtion technique based on the principle of the laminar 
jet break-up, is proposed in its co-axial configuration as single step technique 
for the manufacturing of core-shell particles (145). 
Two concentric nozzles of different dimension, the inner of 400 µm and the 
outer of 600 µm, were used to pump contemporarly different polymer 
solutions obtaining core/shell particles. 
In the current study, the development of a novel aerogel formulation in form 
of polymeric core/shell microcapsules based on alginate and amidated pectin 
and loaded with doxycycline is reported. Alginate with high mannuronic 
content, able to stimulate cytokines production by human monocytes, was 
used as constituent of the shell and as enhancer of the healing process (146). 
Amidated pectin matrix, loaded with doxycycline, was used as core of the 
particles and drug diffusion barrier. Both polymers allow the formation of a 
structured gel able to maintain a balanced transpiration/evaporation 
equilibrium at the wound site. 
Particles were cured using supercritical CO2 (SC-CO2) technique to remove 
solvent from beads allowing the production of aerogels characterized by open 
pore structure and high surface area. Doxycycline (D) was used as a broad 
range spectrum of action antibiotic drug, active against both Gram positive 
and Gram negative bacteria, which both colonize infected wounds. Moreover, 
this antimicrobial agent acts as a protease MMP inhibitor, particularly MMP-9 
(147) and it has shown to be potentially able to inhibit TNF-α converting 
enzyme (TACE) activity (117), therefore to reduce MMP-2 expression in 
chronic wounds leading to the enhancement of the healing. 
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A series of samples were produced (prilling optimized conditions in paragraph 
2.4.1.4) to be tested in terms of morphology, density, gelling ability and drug 
release profiles. 
Core/shell droplets produced by prilling were gelled directly in ethanol, 
producing alcolgel, and were immediately ready for the supercritical drying. 
Doxycycline saturated gelling solution was useful in order to reduce drug 
leaking from the alcolgels during the gelation process. 
 Operative conditions, chosen using the vapour liquid equilibrium diagram 
for the binary system ethanol/CO2 (148, 149) were set at 150 bar, 38°C, and a 
CO2 flow rate of 0.6 Kg/h, as studied in the previous work. The process last 60 
minutes. 
Table 5: description of sample composition, aerogel beads diameter, apparent density, 
sphericity coefficient (SC) and encapsulation efficiency (e.e.) 
 
As showed in the table above, the pectin core solution was always set at 
3.5%w/w in polymer concentration and D was added in a ratio of 0.1 and 0.2. 
The alginate outer layer solution was set at 1.5 and 1.75% w/w. The aerogel 
diameter ranged between 3.25 and 3.27 for beads produced with either the 
lower or the higher alginate concentration and drug/polymers ratio, whereas 
blank aerogel beads mean diameter ranged between 3.23 and 3.26 mm. 
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Complete solvent elimination from the polymeric matrix lead to aerogel beads 
with spherical shape and slight reduction in size (about 10%) compared to the 
uncured particles.  
Blank aerogels showed low density, between 0.26 and 0.29 g/cm3, depending 
on concentration of alginate solution while doxycycline loaded aerogels 
showed slight increase in apparent density, between 0.31 and 0.34 g/cm3, 
depending on concentration of alginate solution and drug-pectin ratio; the 
higher the both the higher the density. This phenomenon can be explained 
looking at the differences in three dimensional gel structure of the alginate and 
pectin into the beads, as highlighted in SEM analyses. In fact, the increase of 
alginate concentration leads to an increase in cross-linking degree and a 
subsequent increase in density while the different gelation mechanisms 
between alginate and pectin into the beads leads to very different polymer 
matrix nanoporous texture. 
 
Figure 52: internal structure of half core/shell aerogel obtained by liquid N2; 
a) alginate shell, b) pectine core.  
Nanoporous structure was not affected by drug loading and no crystals of the 
drug were observed embedded into the matrix probably due the formation 
amorphous doxycycline into the beads. 
Doxycycline encapsulation efficiency (e.e.) was also correlated to the alginate 
layer but unexpectedly the ticker the alginate layer the lower the e.e. This is 
mainly due to the increase in porosity of the alginate outer layer, when higher 
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concentration are processed, that is not compensated by longer diffusional path 
during the SC-CO2 solvent extraction (150).  
Moreover, e.e. decreased also with the increase of drug/polymer ratio due to 
diffusional phenomena strictly related with drug internal concentration. 
The figure below is a comparison between SEM analysis and Fluorescence 
microscopy (FM). SEM photograph evidences the presence of a well formed 
core/shell bead with an alginate outer layer ranging between 175 and 210µm 
for 1.5 and 1.75% alginate concentration, respectively (53 b). FM images 
confirm the good formation of the particle with an evident distribution into the 
pectin core of the drug that was concentrated only in the internal part of the 
beads with very tiny spots located into the alginate shell on the border of the 
pectin core. The presence of such spots was mainly related to the alginate 
concentration.  
 
Figure 53: Fluorescence images of core/shell particles, and of doxycycline raw material 
compared to SEM images. SEM images of a half particle (a), and of alginate shell (b). 
FM image e shows the doxy loaded core, whereas image f shows the unloaded shell 
(blue). 
This phenomenon can be explained looking at the difference in gelation rate 
between the core and the shell of the bead. In fact, the faster gelation of 
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alginate shell, compared to the pectin core, reduces doxycycline diffusion and 
decreases drug leaking into the shell layer. 
Doxycycline has amine groups that could interact with anionic polymer 
residues of pectin and alginate. Such an interaction could be useful to slow 
down drug release rate from beads prolonging the drug efficacy. FT-IR studies 
were conducted in order to verify the presence of such interaction. The 
characteristic peaks of doxycycline are reported in Figure 54. Strong bands 
between 3500 and 3000 cm-1 represented C-H, N-H and O-H absorption while 
stretches of C=O and C=C bonds were present between 1700 and 1600 cm-1, 
1683 and 1614 cm-1, respectively (151). In the same region alginate exhibited 
asymmetric stretching band from the carboxylate ion centered at 1640 cm−1 
and 1420 cm−1, whereas pectin showed stretching vibration of amidated C=O 
at 1740 cm-1 and a band representative of COO- asymmetric stretching 
between 1650 and 1600 cm−1 (152, 153). PDAL formulations showed most of 
the characteristic peaks of doxycycline and polymers but also the presence of a 
new peak centered at 1726 cm-1 that can be associated to the interaction 
between doxycycline and non-amidated acidic residues of pectin. 
 
Figure 54: FT-IR spectra of sodium alginate (a), pectin (b), doxycycline raw materials 
(c), and doxycycline loaded samples PD2AL1 (d) and PD2AL2 (e).   
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The thermal behaviour of pure doxycycline and blank core-shell beads is 
reported in Fig. 55. Doxycycline thermogram exhibited, as expected, the 
profile of a crystalline material with an endothermic melting peak at 168°C 
followed by an exothermic peak at 225°C due to drug degradation. Blank 
beads exhibited the melting of both pectin and alginate complex with Ca+2 as 
broad signals at 155 and 178 °C, respectively, while the presence of an 
exothermic peak at 290°C was related to the polymers decomposition.  
 
 
Figure 55: DSC thermograms of doxycycline hyclate (a), and core-shell pectin-alginate 
beads obtained by coaxial prilling and SC-CO2 drying process: blank beads (b), 
PD2AL1 (c), PD2AL2 (d). 
Doxycycline loaded core-shell beads exhibited similar behaviour to blank 
beads with shifting of the peaks related to the melting of the polymer matrix 
that might be explained by the formation of a complex via amine groups of 
doxycycline and acidic groups of pectin, as shown by FT-IR analysis, too. 
Homogeneous embedding of the drug into the calcium pectinate core 
contributes to shift the melting peak to higher temperature. In fact, the higher 
the content of the drug, the larger the shift. 
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In order to mimic in vitro the ability of the drug loaded aerogels to interact 
with the exudate at wound bed, simulated wound fluid (SWF) (95) was used to 
test both wound exudate uptake ability and drug release. 
Fluid uptake ability was evaluated as the weight ratio of the aerogel in 
hydrated and dry state at different time points when formulation was in contact 
with SWF. As expected, fluid uptake was directly related to polymeric 
content. In fact, formulations exhibited an increase in weight ranging from 7.5 
to 8.1 for PD1ALs and PD2ALs, respectively. Moreover, shrinking of the 
particles was observed before swelling phase. This phenomenon, due to the 
partial collapsing of the alginate shell on the pectin core, was more significant 
and faster for formulations produced with higher alginate content, as shown in 
Figure 56. Swelling of the particles was related to alginate content, too (154). 
In fact, doxycycline loaded beads produced with more diluted alginate 
solutions exhibited a lower increase in size, leading to 50% of the swelling 
endpoint in about 11 min, and to total swelling of the formulation in about 40 
min. Aerogels produced with 1.75% w/w alginate concentration needed about 
50 min to move to completed swelled gel, probably due to the presence of 





Figure 56: The collapse of alginate shell on the pectin core in the first seconds of 
contact with fluids. 
Figure 57 panel A, reports the permeation profiles of both aerogel 
formulations in comparison to pure doxycycline as crystalline raw material. As 
expected for a very soluble drug, total permeation of doxycycline was 
achieved in around 20 min. On the contrary, drug entrapped into the aerogel 
formulations exhibited a prolonged permeation, until 48 h, due to the 
conversion of the beads into hydrogel able to acts as a barrier against drug 
release. Moreover, drug permeation was dependent on both drug/pectin ratio 
and alginate concentration. In fact, PD2AL1 exhibited the higher permeation 
rate releasing almost 55% of the encapsulated drug in about 1 h and achieving 
total release in about 24 hours while PD1AL2 released less than 35% in 1 h 
and needed 48 h to release the entire drug dose. The drug burst effect useful at 
the beginning of an antibiotic therapy can be related to the different amount of 
doxycycline in alginate shell (higher for PD2AL1 and PD1AL1) that collapse 
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over the pectin core during the first contact between aerogels and PBS as well 
as to the formation of a thinner hydrogel. The influence of polymeric shell on 
drug release rate can be highlighted looking at doxycycline permeation 
normalized over alginate shell thickness, as reported in Figure 57 panel B. In 
fact, the amount of doxycycline released by aerogels with thicker shell is 4 
times less than for the ones with thinner layer, while, slightly differences in 
drug release from aerogels produced with the same amount of alginate might 
be due to the presence of the drug into the alginate shell, as for burst effect 
The influence of the polymer chains relaxation process on doxycycline release 
was determined by fitting the experimental data with Peppas-Korsmeyer’s 
equation (using the first 60% of the amount released) (155). All formulations 
presented non-Fickian transport mechanism involving matrix swelling and 
erosion. In fact, the diffusion exponent n was found to be between 0.53 and 
0.58, depending on alginate concentration. Increasing of alginate concentration 
lead to a ticker shell around the pectin core able to reduce drug diffusion. 
Moreover, swelling properties of the core-shell matrix, mainly due to alginate 
external layer of the formed hydrogel affect drug diffusion, which follows a 
complex non-Fickian release mechanism, resulting governed by both matrix 






Figure 57: A- Release profiles of PD2AL1 (green), PD1AL1 (yellow), PD2AL2 (blue), 
PD1AL2 (red) compared to doxycycline raw. B- PD2AL1, PD1AL1, PD2AL2, PD1AL2 
permeation rates normalized on the alginate shell thickness.   
 
In conclusion, prilling technique in tandem with a supercritical CO2 drying 
allowed to efficiently obtain alginate/pectin core/shell aerogel particles, 
spherical in shape and with a good encapsulation efficiency (up to 87%). 
These aerogels consisted of doxycycline entrapped into a pectin core network 
and coated with alginate as shell of the particles. When in contact with a 
simulated wound fluid they were able to swell and move into a gel. This 
ability was directly related to the concentration of alginate in the liquid feeds 
processed by prilling apparatus, with a lower swelling at the lowest polymer 
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concentration. However, all formulations moved into gel status between 40 
and 50 min. Acting as a barrier to doxycycline permeation, pectin and most 
important alginate amount in the processed solutions influenced drug release 
rate. In fact, differently from pure doxycycline that permeates in 20 min, the 
aerogel formulated with the higher amount of alginate in the outer layer is able 
to prolong drug release till 48h by delaying diffusion of the drug through the 
swelled alginate/pectin polymer matrix. Core/shell aerogel particles included 
in gauze can be used as formulations having great potential application in the 








































































From the results obtained by experiments of Felicetta De Cicco performed 
during the period spent at Universidade de Santiago de Compostela, -Santiago 







































3.2.3.1 Norfloxacin and ketoprofen loaded into alginate aerogels: 
prilling/supercritical drying/ supercritical impregnation 
In this part of the Ph.D course, a combined technique based on 
prilling/supercritical drying/supercritical impregnation was applied for aerogel 
beads production. Such technique could be proposed for the development of a 
dextran based topic formulation loaded with norfloxacin and 
norfloxacin/ketoprofen. 
Prilling was used to produce alginate particles in narrow size distribution, 
while supercritical drying, applied to polymeric matrix, allows the production 
of aerogels characterized by open pore structure and high surface area, able to 
control the drug release as also described in the previous studies done in the 
first year of course (149). 
The expertise on prilling and the supercritical based technologies acquired 
during my Ph. D. course was very useful to study the feasibility of prilling 
coupled with supercritical drying and supercritical impregnation. 
Supercritical CO2 (SC-CO2) was also used for drug impregnation in order to 
load particles with norfloxacin and ketoprofen to propose as wound healing 
formulations.  
Aerogels, as showed previously, are characterized by open pore structure with 
high exposed surface area, so they are able to absorb large quantities of 
liquids, as well as exudates, with possible topical applications for wound 
healing. 
Furthermore, objective was to study the effects of this multi-step process on 
aerogels, in terms of particle morphology, drug solid state properties and 
particle apparent density before and after impregnation. 
Feed solution of alginate with high mannuronic residues content, able to 
promote the wound healing, were prepared at different concentrations (1.50- 
2.25% w/w), and processed by prilling. Optimized prilling conditions were 
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used to obtain particles with a narrow size distribution (paragraph). Particles 
were obtained by gelation in both aqueous and ethanolic CaCl2 0.5M solutions 
producing hydrogels and alcogels, respectively. This experimental part was 
conducted at University of Salerno. 
At the University of Santiago de Compostela, Department of Pharmacy and 
Pharmaceutical Technology, the solvent exchange was conducted overnight in 
absolute ethanol with continuous stirring, and then the SC-CO2 assisted drying 
process was conducted under optimized conditions (120 bar, 40°C, 5-7g/min 
for 3.5 h), collecting ethanol every 15 minutes during the first hours and every 
30 minutes for the remaining experiments hours. 
Supercritical drying was successfully conducted on both particles gelled in 
water and ethanol, obtaining aerogels with a nanoporous structure. However, 
impregnation and analysis were conducted only on aerogels obtained by 
hydrogels. 
Norfloxacin was used as model drug, because of its broad spectrum of action, 
as well as ketoprofen was chosen as antinflammatory model drug. Both drugs 
are characterized by a good solubility in SC-CO2, a fundamental condition for 
this process (157, 158). 
     
Figure 58: Norfloxacin (on the left) and ketoprofen (on the right). 
Supercritical impregnation was conducted in order to load aerogel using 
optimized conditions, (pressure 180 bar, temperature 40°C, 6 h, batch 
conditions)(159). Particularly, a specific protocol of depressurization was 
actuated in order to avoid drug amorphisation. 
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Figure 59: internal structure of criofractured particles with liquid N2. a) alginate 
aerogel beads. b) Alginate aerogel beads after impregnation with ketoprofen and 
norfloxacin, c) alginate beads liohpilized after exchange in ethanol. 
Supercritical drying was compared to other drying methods, such as 
convective method (owen at 40°C) and liophilization. SEM images of half 
particles criofractured with liquid N2 were compared. Blank alginate aerogel 
(figure 59 a) exhibited nanoporous internal structure preserved after the 
supercritical drying (75). On the contrary, figure 59 b shows the internal 
structure partially collapsed of an aerogel after impregnation of ketoprofen and 
norfloxacin. Nevertheless, apparent density is increased due to the partial 
embedding of the drug into the matrix and to the impregnation process (table 
6). 
N2 adsorption/desorption method, based on Brunauer-Emmett-Teller theory, 
was used to study the effective porosity of the aerogels. Freeze dried hydrogel 
particles were used as control. 
Aerogel porosity, as expected, was higher compared to freeze dried particles, 
with specific surface area between 172.0219 to 459.7350 m2/g while specific 
surface area for lyophilized particles ranged between 122.9677 to 163.1652 
m2/g.  
 
a b c 
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Figure 60 on the left, BJH desorption curves for aerogel at concentration 1.5, 1.75, 2 
and 2.25% w/w. On the right, BJH desorption curves for liophilized particles with 
solvent exchange at polymer concentration of 1.5, 1.75, 2 and 2.25%w/w. 
The high porosity of the aerogel particles should allow an increased fluid 
uptake ability compared to other formulations, that might be very useful for 
the topical application on wounds. To assess this property, fluid uptake ability 
experiments were performed. Aerogel particles were placed in contact with 
SWF using a specific protocol (paragraph 2.4.2). Particles when in contact 
with the simulated fluid shrinked immediately, then swelling process took 
place after 10 minutes and lasted till one hour. Swelled aerogels were able to 
uptake fluid increasing their weight up to 14 times.  
The impregnation was firstly conducted only with norfloxacin and then with 
norfloxacin and ketoprofen using the same conditions. Drug content and 
encapsulation efficiency were evaluated by means of Uv-vis 
spectrophotometry. 
As showed in the table 6, norfloxacin content was very low, whether the 
process was conducted for both 6 h and 8 h. Furthermore, the value was still 
low when the process was conducted impregnating also ketoprofen. However, 
ketoprofen loading was very high, and a remarkable difference was evident 






Table 6: apparent density before and after impregnation process and loading for 
norfloxacin (N) and norfloxacin/ketoprofen (N/K) for aerogel at 1.5 and 2.25% w/w of 




In conclusion, this study assessed the feasibility of combination of 
prilling/supercritical drying/supercritical impregnation. Hydrogels produced 
by prilling can be easily converted in aerogels, by supercritical process, and 
aerogels can be impregnated with norfloxacin and with 
norfloxacin/ketoprofen. However, further studies are needed to increase 
norfloxacin encapsulation efficiency, optimizing impregnation process. 
Aerogels presented high porosity due to their nanoporous structure, as well as 








































3.3 SECTION C  




















































3.3.1 In situ injectable hydrogel loaded with Annessin 1 like peptide Ac2-26 
The discovery of growth factors (GFs) and their mechanisms of action was a 
strong stimulus to the design of locally controlled release formulations loaded 
with different GF molecules (EGF, VEGF, bFGF, GM-CSF, PDGF-BB). 
Despite the encouraging results from various clinical trials, only PDGF-BB 
has been approved for its use in diabetic ulcers as a gel formulation (160, 161). 
However, it showed a modest efficacy and phase IV investigations highlighted 
significant side effects in patient extensively treated with PDGF (162); 
therefore, other growth-factors and new formulations must be tested and 
developed (163). 
Annexin A1 (ANXA1, lipocortin-1) is the first characterized member of the 
annexin superfamily of proteins, able to bind (to annex) to cellular membranes 
in a Ca2+-dependent way. ANXA1 has been involved in a broad range of 
molecular and cellular processes, including anti-inflammatory signalling, 
kinase activities in signal transduction, maintenance of cytoskeleton and 
extracellular matrix integrity, tissue growth, apoptosis and differentiation 
(164). ANXA1 N-terminal derived peptide Ac2-26 has been used as an 
ANXA1 surrogate in view of its ability to replicate the antiinflammatory 
effects of the parent protein (165). Ac2-26 can activate all three human formyl 
peptide receptors, promoting calcium fluxes, and cell motility (166).  
 
Figure 61: Annessin-1 peptide 3D image. In red, N-terminal peptide Ac2-26.  
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Such an effect may be part of a reparatory process as demonstrated with 
intestinal epithelial cells, skeletal muscle myoblasts and WS1human 
fibroblasts (167-169) where addition of the Ac2-26 peptide engaged FPRs to 
activate the cytoskeletal machinery amplifying the pathway downstream FPR 
activation, contributing to actin polymerization and then favouring cell 
migration and tissue repair. 
Naural biopolymer are known for their ability to enhance wound healing 
process by molecular mechanisms. High M residues content alginate is well 
known for its ability to induce cytokine production by human monocytes, a 
process very useful in chronic wound healing (61). Low molecular weight 
(LMW) chitosan is also able to induce macrophages activation by interaction 
of the acetylated residues with mannose receptors (58). This action as well as 
collagenase activity can be enhanced by chitosan oligomers and monomers 
easy produced by enzymatic degradation of LMW chitosan (170). 
 Furthermore, this kind of carrier are able to retain high quantities of water, 
assuring an appropriate moisture at the wound bed (95, 131). 
In this preliminar study, in situ injectable alginate or chitosan hydrogel 
containing different amounts of Ac2-26 were produced (preparation at 
paragraph2.4.1.6), in order to test the ability on promoting wound healing by 
the synergic effect of polymers and peptides, also finding the right dosage per 
each gel. This ability and other properties of this kind of formulation were 
tested in vitro and in vivo on a murin model. 
The first part of the work included a series of test to evaluate the possibility of 
using in vivo such hydrogels.   
Rheological experiments were performed in order to find the proper polymer 
concentration range to obtain gels able to remain into the wound bed for an 




Alginate concentrations were 2.5 or 5% w/w, whereas chitosan concentrations 
were 3.5 or 6.5%w/w. The table below shows some results for the different 
samples produced: ACA gels are from alginate, whereas ACC series is related 
to chitosan based hydrogels. The resulting gels were in the proper range of 
zero shear viscosity (4100 e 9500 Pa.s) enabling easy administration and 
retention of Ac2-26 loaded gels into wound cavity. In fact, higher η0 would not 
allow clean deposition of gel into the wound bed whereas lower values caused 
gel leaking from the cavity. Furthermore, a fluid loss mid value was 
calculated. 
Table 7: Alginate and chitosan hydrogels at different concentration of polymer and 
Ac2-26. Zero shear rate viscosity and fluid loss mid value. 
 
 Alginate and chitosan gels were loaded with Ac2-26 peptide in order to obtain 
solutions at fixed concentration. On the basis of our previous results on the 
promigratory effects of the peptide on WS1 human fibroblasts in a in vitro 
wound healing assay (169), Ac2-26 gels prepared at three different 
concentrations (100 nM, 500 nM and 1µM) were tested in order to assess 
peptide stability into the polymeric gel matrix over time. Moreover, to 
evaluate the Ac2-26 tendency to interact with alginate or chitosan, quantitative 
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LC/MS analyses were performed to measure the amount of recovered peptide 
following 6 h of incubation into different gels. Specifically, two different 
concentrations of the peptide (100 nM and 1µM) were loaded into four 
different gels (2.5% and 5.0% alginate, 3.5% and 6.5% chitosan). 
Preliminary results showed that the amount of peptide recovered from alginate 
gels was of 82 to 96% of the loaded quantity, whereas only 15% of loaded 
Ac2-26 was recovered from chitosan gels probably due to a chemical 
interaction between peptide and chitosan aminogroups. In order to understand 
this behavior, FT-IR analysis were conducted on dehydrated gels. 
 
 
Figure 62: FTIR spectra of alginate and chitosan Ac2-26 loaded hydrogels in 
comparison with polymer and pure peptide solutions. Panel (A) 5.0% (w/v) high M 
content alginate solution (a), 0.5 M AC2-26 solution (b) and ACA50-500 hydrogel (c). 
Panel (B) 6.5% (w/v) LMW chitosan solution (a), 0.5 M AC2-26 solution (b) and 
ACC65-500 hydrogel (c). 
 Alginate carboxyl peaks at 1644 and 1422 cm−1corresponding to symmetric 
and asymmetric COO- stretching vibration were shifted at 1551 and 1502 
cm−1in Ac2-26 loaded alginate gel (Fig 62) probably due to an extensive 
hydrogen bonding in a crowded environment such as the concentrated alginate 
solution (171) between Ac2-26 and alginate carboxyl group. The FTIR 
spectrum of chitosan in Fig 62 B shows the peaks of amide bond at 1625 cm−1, 
NH2 bending of the protonated amino peaks at 1556 cm
−1due to the presence 
of N-deacetylated groups and the absorption bands at 1153, 1095 and 1074 
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cm−1characteristic of the stretching of its skeletal saccharine structure. N-
related peaks were shifted in Ac2-26 loaded LMWchitosan gel, amide peak 
into singlet band at 1645 cm−1and amino signal to a broad peak at 1545 cm−1, 
both not existing into the Ac2-26 peptide spectrum. Changes in the bands of 
the amide bonds and amino groups can be attributed to an ionic interaction 
between the amino group of chitosan and the region from Asn 16 and Glu 20 
of Ac2-26 peptide that in the ACCs gels bear a negative charge of −2 (172). 
Such negatively charged portion of the peptide could allow an efficient 
binding onto the positive chitosan chain that might prevent Ac2-26 loaded 
chitosan gel to release the peptide under mild pH condition agreement with the 
recovery data obtained by LC/MS. Moreover, the persisting in ACCs 
formulation of the peak related to the chitosan amino groups at 1153 
cm−1suggests the presence of an interaction between chitosan and Ac2-26 in 
agreement with the molar ratio between them. 
In order to verify the ability of gel to maintain correctly hydrated the wound 
during therapy, the water loss after air exposition was studied. The amount of 
gel to be used for the in vivo experiment was put on a support with 200µl of 
simulated wound fluid, and at defined point of time it was weighted. 
 
Figure 63: Water loss of 1M AC2-26 loaded hydrogels at different concentrations: high 
M content alginate 5.0% ( ) and 2.5% ( ), LMW chitosan 6.5% ( ) and 3.5% ( ).  
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As shown in the figure 63 all the formulations have an exponential weight loss 
during the first 24 hours followed by a linear kinetic between 24 and 72 hours. 
This may explained by the formation of a polymer enriched layer on the 
surface of the gel able to retard further water desorption (173). However, mid-
value of deswelling (fifty percent of fluid loss) was reached in about 42 or 55 
h for chitosan and alginate gels, respectively; whereas, dry state was reached 
between 120 and 132 h depending on polymer concentration. Moreover, fluid 
loss was also related to polymer concentration. In fact, the higher the 
concentration the slower the desorption kinetic. 
Peptide release kinetic was studied using an in vitro test. A dyalisis membrane 
of 10K with an exposed area of 0.33 cm2 was used.  The system, thermostated 
at 37°C and stirred at 200 rpm with SWF in the donor compartment was filled 
with 250 μl of gel. At defined point of time 100 μl samples were collected and 
LC-MS detected (paragraph 2.4.2). As expected, release profiles were directly 
correlated to peptide and polymer concentration. Release ranged between 4 to 
72 hours and all gels showed a reduction in peptide concentration between 24 
to 96 h due to degradation phenomena in SWF at 37°C. This data demonstrate 
that polymers are able to protect peptide for a long time compared to peptide 
raw that degradates in a few hours (174). 
Moreover, alginate/peptide gels exhibited a burst effect within 2 h related to 
alginate concentration, resulting in the release of about 90% of the peptide for 
ACA25 gels while after 2 h ACA50-100 and ACA50-1000 formulations 
released 69 and 52% of the loaded peptide, respectively. 
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Ac2-26 0.1 M Alginate 5.0%
Ac2-26 1.0 M Alginate 5.0%
Ac2-26 0.1 M Alginate 2.5%
Ac2-26 1.0 M Alginate 2.5%

















Figure 64: Release profiles of AC2-26 loaded alginate gels at different concentrations: 
ACA25-100 ( ), ACA25-1000 ( ), ACA50-100 ( ) and ACA50-1000 ( ) and of AC2-26 
loaded chitosan gel at 3.5%: ACC35-1000 ( ). Mean ± SD; (n = 6).  
Such intensive release of the active in the first hours of administration, 
followed by a prolonged release, may be very useful at the beginning of the 
healing process that could benefit of the strong antiinflammatory and pro-
migratory effects related to high concentration of Ac2-26 (175). 
In spite of similar viscosity behaviour, diffusion of AC2-26 from 
chitosan/peptide formulations was very poor with very slow release rate, 
reaching around 10% in about 72 h even for the most concentrated peptide gel 
This phenomenon was correlated to the strong interaction between Asn 16 and 
Glu 20 ofAc2-26 and LMW chitosan, as highlighted by FTIR analyses. 
In vivo tests were conducted on C57BL/6 mice (Harlan Laboratories, 
Indianapolis, IN, USA) according to protocols that followed the Italian and 
European Community Council for Animal Care (DL. no. 116/92). 
On the day of surgery, the hair on the back of eachmouse was clipped, and the 
skin was wiped with ethanol. C57BL/6mice, 10 weeks of age, were 




Figure 65: An example of laboratory mouse. 
Full-thickness excision wounds (1 cm × 1 cm) were created by marking the 
area of the wound in the shaved mid back with a fine marker and a ruler. 
These tests were useful to show the effective healing potential of the hydrogels 
and to confirm the in vitro tests results. Only alginate hydrogels were used 
because chitosan is not able to assure a correct peptide release, as 
demonstrated by the previous analysis. 
A series of mouse were treated only with saline solution as comparison 
(negative signal). Then mice were treated with alginate, and with alginate 





Figure 66: (A) Ac2-26 loaded alginate hydrogel ameliorates skin wound repair in acute 
skin wound healing. Full-thickness skin wounds (1 cm × 1 cm) in C57BL/6 mice were 
treated with: (a) 5.0% blank alginate hydrogel or loaded with an optimized 
concentration of (b) Ac2-26 100 nM, (c) Ac2-26 500 nM, (d) Ac2-26 1 µM (n = 3 mice 
per peptide, per experiment. Plus signs indicate treated mice, and minus signs indicate 
control mice. The images of 1 representative experiment are shown. (B) Measurements 
of blank alginate hydrogel vs Ac2-26 loaded alginate hydrogel in acute wound healing. 
Percentage of the accelerated wound closure at days 0, 3, 6, 9, and 14 after treatments 
with ACA50s hydrogel formulations or blank alginate hydrogel vs control ((a)–(d)) 
(mean ± SD). P ≤ 0.05, compared with control or blank alginate hydrogel. 
Standardized digital photographs of the wounds were taken with the same 
distance between camera and pre-anesthetized mouse, for each animal. The 
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photographs were examined using planimetry for objective evaluation for 
degree of wound healing (176). The total pixels that cover the unhealed areas 
were drawn onto the digital photographs using a pattern overlayin Image J, 
(Image J software, Wayne Rasband, National Institute of Health, Bethesda, 
MD, USA). The number of pixels covering an open wound area on a given 
day was divided by the number of pixels spreading over the initial wound on 
day 0 to obtain the percentage of closure. Percentage, rather than actual 
distance (e.g., mm), of wound closure was calculated from the measured 
wound areas (pixel density). This method allows more accurate measurements 
of the wounds, considering the fact that certain margin of errors during 
surgical procedures may exist among different experimental groups or even 
among the three mice within the same group (177). 
As showed by the graph a, in which alginate and the control were compared, 
alginate is more effective than control at the third day already, obtaining an 
effective wound closure at the fourtheenth day. Graph b compares alginate 
without active and alginate plus Ac2-26 at the lowest concentration (0.1µM) 
and it shows that there is any significative difference between them. Graph c 
shows that Ac2-26 at the concentration of 0.5µM allows to control the wound 
closure better than alginate since third day, whereas the maximum 
concentratio (1µM) allows to obtain a complete wound closure at the 14° day 
(graph d). This can be explained by the FT-IR results, that show an extensive 
hydrogen bonding between alginate and peptide in a crowded environment 
such as the concentrated polymer solution demonstrated by the signal shift for 
COO- groups in the loaded formulation. This phenomenon is more evident at 
low concentration, with a similar behavior between alginate and loaded 
alginate. When concentration is higher the activity of Ac2-26 is less 





In conclusion, this study demonstrated that incorporating the ANXA1 mimetic 
peptide Ac2-26 in high M content alginate or LMW chitosan it is possible, 
obtaining an increase in peptide stability as well as a suitable dressing to avoid 
removal problems and living tissue dehydration over time considering 
viscosity, gel mid-value deswelling and dry state time point (120–132 h) of the 
hydrogels. FTIR studies supported by LC-MS results suggest a binding 
between the negatively charged portion of the peptide and the positive 
chitosan chain as an extensive hydrogen bonding between Ac2-26 and alginate 
that stabilizes the peptide when incorporated into the hydrogels. Such 
interactions are able to slow down peptide release from alginate and prevent 
its permeation from chitosan. In vivo tests, showed an acceleration of wound 
closure compared with the topical application of unloaded alginate (especially 
with 0.5 and 1 µM Ac2-26/alginate formulations) allowing 97% of wound 































































































This project was focused on the production of innovative polymer based 
formulation able to promote wound healing. 
The innovative technologies proposed were successfully applied for the 
production of in situ gelling formulations, both dry powders and aerogels. 
Supercritical assisted atomization, applied for gentamicin, alginate and pectin 
powder formulations, demonstrated to be able to produce stable powders with 
uniform morphology and narrow size distribution, proper technological 
properties, useful for topical applications. Formulations showed to be able to 
overcome the hygroscopicity of the gentamicin stabilizing drug content and 
strongly reducing water uptake over time. Moreover, SAA formulations were 
able to efficiently contrast S. aureus and P. aeruginosa growth, till 24 days. 
The optimized process parameters produced reproducible results, particularly 
very high yields, without waste of energy and time and ebabling the recycling 
of CO2. 
The tandem technique prilling/SAE was optimized to obtain aerogels with 
desired size and narrow size distribution. Aerogels presented very high 
porosity as well as low density due to their nanoporous structure. Absorbance 
of large quantities of exhudates was promoted by these properties. In fact, 
aerogels were able to uptake wound fluids till 14 times their weight. A further 
optimization of tandem technique, using prilling in co-axial configuration, was 
applied for the production of core/shell aerogels loaded with doxycycline. 
These formulations showed very short gelation time uptaking large amount of 
exhudates, drug stability over time and were able to prolong drug release 
depending on the tuning of the alginate shell thickness. 
Supercritical impregnation, tested at the Univerisity of Santiago de 
Compostela, was successfully applied for the loading of drugs into pre-formed 
aerogels, with high encapsulation efficiencies. Particles were characterized by 
high porosity and narrow size distribution. Good encapsulation efficiency was 
obtained particularly using ketoprofen at the tested impregnation conditions. 
152 
 
Nano spray drying was successfully applied to the formulations of 
nanopaticulate in situ gelling powders (≈ 350 nm diameter) by setting proper 
operative conditions. 
This technique was applied for the production of alginate and pectin blend 
particles loaded with gentamicin, as well as for the production of a three 
components polymer blend (alginate, chitosan and amidated pectin) containing 
doxycycline. This technique allowed to obtain particles with uniform 
morphology, high yields and high encapsulation efficiencies. All formulations 
were able to control drug release rate in vitro, were able to overcome drug 
stability problems, even in harsh conditions and demonstrated enhanced 
antimicrobial activity over time on both S. aureus and P. aeruginosa strain.  
Natural polymers chosen as carrier in this work showed to be very intersting 
for wound healing applications due to their intrinsic properties, such as 
biodegradability and biocompatibility, as well as the ability to induce the 
wound healing process by different mechanisms. 
Because of their ability to encapsulate and protect active molecules from 
external environment, alginate and chitosan were tested also for the delivery of 
a macromolecule, Ac2-26 Annessin1-like N-terminal peptide, known for its 
ability to promote wound healing. Despite its instability at standard conditions, 
Ac2-26 encapsulated in alginate and chitosan hydrogels showed an increased 
stability at physiological conditions. Moreover, due to the drug/polymers 
interaction, formulations showed to be able to control drug release profiles up 
to 72h. Particularly alginate/Ac2-26 loaded formulation showed, in vivo, a 
very intersting activity, promoting complete wound closure on mice at the 14th 
day of treatment reducing wound closure time up to 60%.  
Interesting technological properties, such as good transpiration properties, 
proper adhesiveness, fluid uptake abilities make all the formulation produced 
in this work interesting devices able to overcome high costs, poor 
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conformability problems, occlusiveness and traumatic removal that 
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